<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Burns Trauma</journal-id><journal-id journal-id-type="iso-abbrev">Burns Trauma</journal-id><journal-title-group><journal-title>Burns &#x00026; Trauma</journal-title></journal-title-group><issn pub-type="ppub">2321-3868</issn><issn pub-type="epub">2321-3876</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29721511</article-id><article-id pub-id-type="pmc">5910591</article-id><article-id pub-id-type="publisher-id">113</article-id><article-id pub-id-type="doi">10.1186/s41038-018-0113-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Vitamin D status and its influence on outcomes following major burn injury and critical illness</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1871-8219</contrib-id><name><surname>Al-Tarrah</surname><given-names>Khaled</given-names></name><address><email>kxa455@bham.ac.uk</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hewison</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Moiemen</surname><given-names>Naiem</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Lord</surname><given-names>Janet M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7486</institution-id><institution-id institution-id-type="GRID">grid.6572.6</institution-id><institution>Institute of Inflammation and Ageing, </institution><institution>Birmingham University Medical School, </institution></institution-wrap>Birmingham, B15 2TT UK </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0400 5079</institution-id><institution-id institution-id-type="GRID">grid.412570.5</institution-id><institution>Scar Free Foundation Centre for Burns Research, </institution><institution>University Hospital Birmingham Foundation Trust, </institution></institution-wrap>Birmingham, B15 2WB UK </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7486</institution-id><institution-id institution-id-type="GRID">grid.6572.6</institution-id><institution>Institute of Metabolism and Systems Research and Centre for Endocrinology Diabetes and Metabolism, </institution><institution>The University of Birmingham, </institution></institution-wrap>Birmingham, B15 2TT UK </aff></contrib-group><pub-date pub-type="epub"><day>16</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>16</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>6</volume><elocation-id>11</elocation-id><history><date date-type="received"><day>29</day><month>1</month><year>2018</year></date><date date-type="accepted"><day>23</day><month>3</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Vitamin D deficiency is common among the general population. It is also observed in up to 76% of critically ill patients. Despite the high prevalence of hypovitaminosis D in critical illness, vitamin D is often overlooked by medical staff as the clinical implications and consequences of vitamin D deficiency in acute contexts remain to be fully understood. Vitamin D has a broad range of pleotropic effects on various processes and systems including the immune-inflammatory response. 1&#x003b1;,25-dihydroxyvitamin D (1,25(OH)<sub>2</sub>D), has been shown to promote a tolerogenic immune response limiting deleterious inflammatory effects, modulation of the innate immune system, and enhancement of anti-microbial peptides. Vitamin D deficiency is frequently observed in critically ill patients and has been related to extrinsic causes (i.e., limited sunlight exposure), magnitude of injury/illness, or the treatment started by medical doctors including fluid resuscitation. Low levels of vitamin D in critically ill patients have been associated with sepsis, organ failure, and mortality. Despite this, there are subpopulations of critical illness, such as burn patients, where the literature regarding vitamin D status and its influence on outcomes remain insufficient. Thermal injury results in damage to both burned and non-burned tissues, as well as induces an exaggerated and persistent immune-inflammatory and hypermetabolic response. In this review, we propose potential mechanisms in which burn injury affects the vitamin D status and summarizes current literature investigating the influence of vitamin D status on outcomes. In addition, we reviewed the literature and trials investigating vitamin D supplementation in critically ill patients and discuss the therapeutic potential of vitamin D supplementation in burn and critically ill patients. We also highlight current limitations of studies that have investigated vitamin D status and supplementation in critical illness. Thermal injury influences vitamin D status. More studies investigating vitamin D depletion in burn patients and its influence on prognosis, via standardized methodology, are required to reach definitive conclusions and influence clinical practice.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Vitamin D</kwd><kwd>Critical care</kwd><kwd>Burns</kwd><kwd>Trauma</kwd><kwd>Thermal injury</kwd><kwd>Critically ill</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par13">Vitamin D insufficiency and deficiency is common in the general population [<xref ref-type="bibr" rid="CR1">1</xref>] and can be present at up to 76% in critically ill patients [<xref ref-type="bibr" rid="CR2">2</xref>]. This is concerning as vitamin D is increasingly recognized for its wide-ranging biological effects, including modulation of bone metabolism and muscle mass, enhancing immune function and cardiovascular effects [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Despite these roles, the clinical implications of hypovitaminosis D remain partially understood and therefore often overlooked in acute clinical contexts including burns and trauma. The literature investigating vitamin D deficiency and its consequences in adult burn patients is limited. Following thermal injury, patients are at prone to develop low vitamin D levels, the impact on short and long-term outcomes of which are relatively unknown.</p><p id="Par14">This review aims to discuss current understanding of vitamin D and its role in critically ill patients, the effect of burn injury on vitamin D status, the influence of vitamin D levels on outcomes in burn patients, the therapeutic potential of vitamin D, and current knowledge gaps.</p></sec><sec id="Sec2"><title>Review</title><sec id="Sec3"><title>Overview of vitamin D axis</title><p id="Par15">Sunlight and nutrition, including dietary supplementation, are the main sources of vitamin D in humans. Solar ultraviolet B radiation infiltrates the skin converting 7-dehydrocholesterol (7-DHC) to pre-vitamin D<sub>3</sub> (pre-D<sub>3</sub>), which is subsequently converted to vitamin D<sub>3</sub> [<xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref>]. Vitamin D (D<sub>2</sub> and D<sub>3</sub>) is also found naturally in certain foods (oily fish, mushrooms, egg yolk) and fortified food products, including cereals, cheese, and milk [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Vitamin D from the skin and diet is then transported to the liver bound to vitamin D-binding protein (VDBP) and albumin, where it is hydroxylated to 25-hydroxyvitamin D (25(OH)D) [<xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref>]. This is used to determine a patient&#x02019;s vitamin D status. 25(OH)D is then metabolized by the enzyme 25-hydroxyvitamin D-1&#x003b1;hydroxylase (CYP27B1) in the kidneys to the active form of vitamin D, 1&#x003b1;,25-dihydroxyvitamin D (1,25(OH)<sub>2</sub>D) [<xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref>], which is then transported to various target cells and tissues where it interacts with intracellular vitamin D receptors (VDRs) to exert transcriptional effects. In addition to the kidneys, various extra-renal sites (such as macrophages) are reported to contain CYP27B1 permitting direct metabolism of 25(OH)D to exert pleotropic effects via autocrine means [<xref ref-type="bibr" rid="CR7">7</xref>] (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Overview of the vitamin D axis</p></caption><graphic xlink:href="41038_2018_113_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec4"><title>Overview of vitamin D biological effects</title><p id="Par16">Classically, vitamin D is associated with musculoskeletal health by maintaining calcium homeostasis and bone mineralization, decreasing the risk of muscle weakness, osteopenia, osteoporosis, and fractures [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Vitamin D exerts most of its physiological effects via 1,25(OH)<sub>2</sub>D which when bound to its cognate nuclear VDR is able to act as a transcription factor in concert with its retinoid X receptor heterodimer partner [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Gene expression analysis of 53 different tissues from over 500 human donors has shown VDR gene expression in more than half of samples including the adipose tissue, adrenal glands, bladder, colon, fibroblasts, kidney, liver, lung, lymphocytes, pituitary glands, and skin [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Accordingly, vitamin D actions are not limited to the skeletal system. The effects of vitamin D on various cell types and tissues are summarized in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Effects of vitamin D on various human cell types and tissues</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Target cells/tissues</th><th>Effects of vitamin D</th><th>Reference</th></tr></thead><tbody><tr><td>Adipocytes</td><td>&#x02022; Inhibits intracellular fat accumulation<break/>&#x02022; Enhances basal lipolysis without cell toxicity<break/>&#x02022; Upregulation of &#x003b2;-oxidation-related genes, lipolytic enzymes, and vitamin D-responsive genes<break/>&#x02022; Increased levels of nicotinamide adenine dinucleotide and sirtulin 1 expression</td><td>[<xref ref-type="bibr" rid="CR105">105</xref>]</td></tr><tr><td>Cardiomyocytes</td><td>&#x02022; Inhibition of cell proliferation without apoptosis<break/>&#x02022; Downregulation of expression of genes associated with cell cycle regulation<break/>&#x02022; Promotes cardiomyotube formation<break/>&#x02022; Induces cardiac differentiation</td><td>[<xref ref-type="bibr" rid="CR106">106</xref>, <xref ref-type="bibr" rid="CR107">107</xref>]</td></tr><tr><td>Hepatocytes</td><td>&#x02022; Protects against insulin resistance<break/>&#x02022; Downregulates fibrogenic TGF-&#x003b2; signaling<break/>&#x02022; Anti-inflammatory effects by inhibiting monocyte activation and TNF-&#x003b1; and IL-1 expression</td><td>[<xref ref-type="bibr" rid="CR108">108</xref>&#x02013;<xref ref-type="bibr" rid="CR110">110</xref>]</td></tr><tr><td>Myocytes</td><td>&#x02022; Modulation of calcium homeostasis and influx<break/>&#x02022; Induces cellular proliferation and differentiation<break/>&#x02022; Protects against insulin resistance<break/>&#x02022; Stimulation of arachidonic acid mobilization</td><td>[<xref ref-type="bibr" rid="CR111">111</xref>, <xref ref-type="bibr" rid="CR112">112</xref>]</td></tr><tr><td>Nephrocytes</td><td>&#x02022; Upregulation of cellular metabolic activity, IL-6, and reactive oxygen species<break/>&#x02022; Restoration of transepithelial barrier function</td><td>[<xref ref-type="bibr" rid="CR113">113</xref>]</td></tr><tr><td>Neurons</td><td>&#x02022; Neuroactive steroid modulating spontaneous regular firing, actin potential duration, and intrinsic excitability<break/>&#x02022; Enhances sensitivity to neurotransmitters and neurotransmitter receptors<break/>&#x02022; Upregulation of neuronal growth factors, neurotrophin 3, and glial cell line-derived neurotrophic factor</td><td>[<xref ref-type="bibr" rid="CR114">114</xref>, <xref ref-type="bibr" rid="CR115">115</xref>]</td></tr><tr><td>T cells</td><td>&#x02022; Inhibits Th1/Th17 chemokine/cytokine secretion (CXCL-10, IFN-&#x003b3;, TNF-&#x003b1;, and IL-17)<break/>&#x02022; Enhances Th2 cytokine release (IL-4 and IL-5)</td><td>[<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR116">116</xref>]</td></tr><tr><td>B cells</td><td>&#x02022; Downregulates the proliferation of memory B cells<break/>&#x02022; Inhibits plasma cell differentiation<break/>&#x02022; Reduces Ig production</td><td>[<xref ref-type="bibr" rid="CR117">117</xref>]</td></tr><tr><td>Antigen-presenting cells</td><td>&#x02022; Inhibits the expression of class II MHC molecules (HLA-DR)<break/>&#x02022; Inhibition of co-stimulating molecule expression (CD80, CD83, and CD86)<break/>&#x02022; Augments chemotaxis and phagocytosis of monocytes<break/>&#x02022; Downregulates the maturation of dendritic cells<break/>&#x02022; Induces tolerogenic dendritic cells capable of inducing Treg cells<break/>&#x02022; Inhibits IL-12 p70 release<break/>&#x02022; Decreases macrophage-stimulated pro-inflammatory cytokine production (IL-1, IL-1&#x003b2;, IL-6, IL-8, MCP-1, and RANTES)</td><td>[<xref ref-type="bibr" rid="CR118">118</xref>&#x02013;<xref ref-type="bibr" rid="CR121">121</xref>]</td></tr><tr><td>NK cells</td><td>&#x02022; Inhibition of NK cell development and differentiation<break/>&#x02022; Reduced INF-&#x003b3; and cytotoxicity</td><td>[<xref ref-type="bibr" rid="CR122">122</xref>]</td></tr></tbody></table><table-wrap-foot><p><italic>TGF-&#x003b2;</italic>&#x000a0;Transforming growth factor-&#x003b2;,&#x000a0;<italic>TNF-&#x003b1;</italic>&#x000a0;Tumor necrosis factor,&#x000a0;<italic>IL</italic>&#x000a0;Interleukin, <italic>IFN-&#x003b3;</italic>&#x000a0;Interferon-&#x003b3;,&#x000a0;MCP-1 Monocyte chemotactic protein 1,&#x000a0;<italic>NK</italic> Natural killer&#x000a0;</p></table-wrap-foot></table-wrap></p><p id="Par17">Of relevance to this review, vitamin D has a broad range of beneficial effects on the immune system [<xref ref-type="bibr" rid="CR12">12</xref>]. An association between the adaptive immune system and vitamin D status was initially observed when VDR levels were shown to be enhanced in activated T and B cells [<xref ref-type="bibr" rid="CR13">13</xref>]. In VDR-expressing T cells, 1,25(OH)<sub>2</sub>D promotes a tolerogenic immune response by favoring Th2 and Treg cell differentiation over the more inflammatory Th1 and Th17 cells, thereby limiting deleterious inflammatory activity [<xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref>]. Other immune-modulatory effects of vitamin D include differential modulation of the response of the innate immune system (monocytes, macrophages and dendritic cells) [<xref ref-type="bibr" rid="CR19">19</xref>] with upregulation of anti-microbial peptides such as cathelicidin and &#x003b2;-defensin 2 from various cells including human keratinocytes and intestinal epithelial cells [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], enhancement of autophagy of intracellular microbes [<xref ref-type="bibr" rid="CR22">22</xref>], and regulation of antigen-presentation in dendritic cells, monocytes and macrophages to facilitate a non-exaggerated immune response [<xref ref-type="bibr" rid="CR23">23</xref>]. Crucially, antigen-presenting cells from the innate immune system express the vitamin D-activating enzyme CYP27B1 and are therefore able to metabolize 25(OH)D in a tissue-specific fashion [<xref ref-type="bibr" rid="CR24">24</xref>]. This &#x0201c;intracrine&#x0201d; mode of 25(OH)D metabolism appears to be the principal mechanism by which vitamin D is able to regulate T cell function [<xref ref-type="bibr" rid="CR25">25</xref>] and provides a mechanism by which vitamin D deficiency (low serum 25(OH)D) can influence immune function. The various effects of vitamin D upon the immune response are summarized in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.</p><p id="Par18">DBP and albumin are the main transporters of vitamin D. However, sterol-binding capacity is not the only attribute of DBP and albumin. Multiple roles of DBP have been described including actin scavenging, binding of fatty acids and endotoxins, modulation of immune and innate immune responses, and influence on bone metabolism via DBP-macrophage activating factor [<xref ref-type="bibr" rid="CR26">26</xref>]. Albumin has been reported to exert antioxidant, immune-modulatory, and anti-inflammatory effects, as well as antibiotic transportation and endothelial stabilization [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>].</p></sec><sec id="Sec5"><title>Vitamin D in critically ill and trauma patients</title><p id="Par19">Considering the pleotropic effects of vitamin D, its role in the severely ill has been a subject of growing interest. Thousands of patients are admitted to intensive care units (ICUs) each year [<xref ref-type="bibr" rid="CR29">29</xref>], and up to 77% of critically ill patients have vitamin D deficiency [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR30">30</xref>&#x02013;<xref ref-type="bibr" rid="CR33">33</xref>]. Alizadeh et al. reported that 74% of critically ill surgical patients exhibited vitamin D deficiency [<xref ref-type="bibr" rid="CR34">34</xref>]. Similarly, Dickerson et al. reported that 76% of critically ill patients following traumatic injury were vitamin D deficient or severely deficient [<xref ref-type="bibr" rid="CR2">2</xref>]. In such contexts, it is important to recognize patient demographic factors that may be associated with vitamin D deficiency including age, ethnic group (skin pigmentation), obesity, medical history (such as malabsorption pathologies and liver/renal disease), season, latitude, and time of day [<xref ref-type="bibr" rid="CR4">4</xref>]. However, it is also vital to comprehend that vitamin D deficiency may itself be a consequence of illness.</p><p id="Par20">Low serum 25(OH)D levels has shown a significant association with the magnitude of the critical illness and systemic inflammatory response syndrome (SIRS) [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. The well-documented immunomodulatory effects of 1,25(OH)<sub>2</sub>D suggest that vitamin D deficiency may be a causative factor for critical illness and resulting morbidity and mortality. The observed vitamin D deficiency in critically ill and trauma patients may be due to diminished epidermal vitamin D production secondary to limited sunlight exposure and malnutrition, as well as enhanced conversion of 25(OH)D to active 1,25(OH)<sub>2</sub>D to meet increased tissue demand, notably to promote 1,25(OH)2D-mediated immunoregulatory effects [<xref ref-type="bibr" rid="CR37">37</xref>]. Finally, critical illness, notably in the setting of inflammation, may promote enhanced catabolism of 25(OH)D and 1,25(OH)<sub>2</sub>D to downstream metabolites via the enzyme 24-hydroxylase (CYP24A1) [<xref ref-type="bibr" rid="CR38">38</xref>]. Interpretation of circulating vitamin D levels in critical illness is further complicated by the fact that critically ill patients usually require major fluid resuscitation resulting in low levels of 25(OH)D and 1,25(OH)<sub>2</sub>D secondary to acute fluid shifts and hemodilution [<xref ref-type="bibr" rid="CR39">39</xref>]. Vitamin D concentration in critically ill patients post-resuscitation may take, at least, a few days to recover [<xref ref-type="bibr" rid="CR39">39</xref>]. Secondly, VDBP and albumin levels fall, as part of the systemic inflammatory response, reducing plasma levels of 25(OH)D significantly [<xref ref-type="bibr" rid="CR40">40</xref>&#x02013;<xref ref-type="bibr" rid="CR42">42</xref>]. This appears to be the case in the acute phase of the response to injury. Furthermore, disruption of the vitamin D axis in ICU patients can be attributed to hepatic, parathyroid, and renal dysfunction, as well as reduced end organ resistance [<xref ref-type="bibr" rid="CR43">43</xref>].</p><p id="Par21">Clinical studies have associated low levels of circulating vitamin D with various poor outcomes in critically ill patients including sepsis [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>], organ failure [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>], and short- and long-term mortality [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. Similar findings have also been reported among both critically ill surgical or trauma patients. For example, low vitamin D levels correlated with higher infection rates, length of stay, duration of organ dysfunction, ICU readmission, surgical intensive care treatment costs, and mortality [<xref ref-type="bibr" rid="CR50">50</xref>&#x02013;<xref ref-type="bibr" rid="CR53">53</xref>]. However, such associations are not universal; other observational studies have reported no association between vitamin D deficiency, sepsis, and mortality [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>], as well as other ICU outcomes such as duration of ventilation and length of stay [<xref ref-type="bibr" rid="CR56">56</xref>]. Despite this, several meta-analysis studies have concluded that vitamin D deficiency is associated with significantly increased susceptibility to infections and sepsis, as well as greater incidence of mortality in critically ill patients [<xref ref-type="bibr" rid="CR57">57</xref>&#x02013;<xref ref-type="bibr" rid="CR59">59</xref>].</p></sec><sec id="Sec6"><title>Burn injury pathophysiology and its impact on vitamin D levels</title><p id="Par22">Critically ill populations are clearly identified to be at risk of vitamin D deficiency, but there are sub-populations where there is insufficient literature on the status of vitamin D and its influence on outcomes, including patients with thermal injuries. Although studies investigating vitamin D levels in burns patients are scarce, vitamin D levels have been shown to decrease following thermal injury [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]. This may be both as a primary effect of the injury or secondary response to the injury itself and/or the clinical management initiated such as fluid resuscitation and use of pressure garments.</p><p id="Par23">Burn is a severe form of injury associated with a marked pathophysiological immune-inflammatory response. Thermal injury induces a unique &#x0201c;genomic storm&#x0201d; altering 80% of the leukocyte transcriptome leading to prolonged simultaneous and rapid stimulation of innate (both pro- and anti-inflammatory genes) and suppression of adaptive immune responses [<xref ref-type="bibr" rid="CR62">62</xref>]. Clinical studies have recently characterized the immune response following burn injury demonstrating prolonged neutrophil dysfunction and release of immature granulocytes lasting up to 28&#x000a0;days [<xref ref-type="bibr" rid="CR63">63</xref>], reduced numbers and impaired expression of CD14 +/HLA-DR + monocytes persisting up to 30&#x000a0;days [<xref ref-type="bibr" rid="CR64">64</xref>], and downregulation of NKG2D (a natural cytotoxicity receptor in natural killer cells) ligands resulting in immunosuppression [<xref ref-type="bibr" rid="CR65">65</xref>]. The presence of concurrent upregulation of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-10, and other cytokines following injury indicates an over-compensating response by the body [<xref ref-type="bibr" rid="CR66">66</xref>], which may last for up to 3&#x000a0;years post-burn [<xref ref-type="bibr" rid="CR67">67</xref>].</p><p id="Par24">Thermal injury is associated with a hypermetabolic response. The metabolic changes in burn injury and other forms of trauma are similar but differ in magnitude and persistence. These changes are characterized as a two-phase response: the &#x0201c;ebb&#x0201d; phase within 48&#x000a0;h where metabolism, cardiac output, and oxygen consumption are reduced, followed by the &#x0201c;flow&#x0201d; phase at approximately 120&#x000a0;h post-injury where these parameters increase and plateau [<xref ref-type="bibr" rid="CR68">68</xref>]. This metabolic response involves peripheral lipolysis and free fatty acid [<xref ref-type="bibr" rid="CR69">69</xref>] oxidations leading to acute, global, and complex increase in serum FFA levels [<xref ref-type="bibr" rid="CR70">70</xref>]; browning of subcutaneous white adipose tissue [<xref ref-type="bibr" rid="CR71">71</xref>]; systemic induction of endoplasmic reticulum (ER) stress and unfolded protein response [<xref ref-type="bibr" rid="CR72">72</xref>]; and up to a sixfold increase in breakdown rates of skeletal muscle protein [<xref ref-type="bibr" rid="CR73">73</xref>]. It is estimated that severe burns cause a surge of resting energy expenditure up to 140% [<xref ref-type="bibr" rid="CR74">74</xref>], which can be prolonged [<xref ref-type="bibr" rid="CR67">67</xref>]. This persistent hypercatabolic, hyperinflammatory response leads to wasting of the patient&#x02019;s tissues and organ, ultimately leading to poorer outcomes.</p><p id="Par25">In addition, fluid and proteins are translocated into burned and non-burned tissues leading to hypovolemia, damaging tissues through direct and indirect means [<xref ref-type="bibr" rid="CR75">75</xref>]. The extent of which is reflected by elevated levels of damage-associated molecular patterns (DAMPs) such as high-mobility group box protein 1 following burn injury [<xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR77">77</xref>]. There is also disruption of local and systemic vascular permeability via the margination of immune cells including neutrophils, macrophages, and lymphocytes, as well as various inflammatory mediators [<xref ref-type="bibr" rid="CR78">78</xref>]. This ultimately leads to an instant shift of intravascular fluid to the interstitial space. To address this issue and circumvent the consequences of hypo/hypervolemia, multiple formulations have been established throughout burn care history to optimize fluid resuscitation [<xref ref-type="bibr" rid="CR79">79</xref>].</p><p id="Par26">Severe burn injury thus induces persistent disturbances of multiple immuno-inflammatory and physiological responses simultaneously, befitting the designation: persistent inflammation, immunosuppression, and catabolism syndrome, PICS [<xref ref-type="bibr" rid="CR80">80</xref>]. This includes reduced circulating levels of vitamin D and its carrier proteins, VDBP and albumin [<xref ref-type="bibr" rid="CR61">61</xref>]. Based on literature concerning non-burn and burn trauma, we propose that this can be explained through a variety of potential mechanisms: First, as previously postulated [<xref ref-type="bibr" rid="CR37">37</xref>], there may be attempts to maintain immune homeostasis via increased conversion of 25(OH)D to active 1,25(OH)<sub>2</sub>D, thereby reducing circulating 25(OH)D levels. In individuals who are vitamin D-sufficient prior to injury, this effect may have a negligible impact on serum 25(OH)D status, but for those who are vitamin D-deficient at injury, this effect may lead to exacerbation of low serum 25(OH)D concentrations; second, fluid resuscitation and a compromised vascular integrity results in decreased serum levels of vitamin D and its metabolites secondary to hemodilution and fluid shifts [<xref ref-type="bibr" rid="CR39">39</xref>]. VDBP and albumin are also affected in the acute response, thereby reducing bound vitamin D levels and impacting its delivery to target tissues [<xref ref-type="bibr" rid="CR40">40</xref>&#x02013;<xref ref-type="bibr" rid="CR42">42</xref>]. This phenomenon of binding protein extravasation would be temporary as microvascular integrity is re-established 6&#x000a0;h following thermal injury [<xref ref-type="bibr" rid="CR81">81</xref>]. Third, VDBP levels are reduced in the acute stage buffering actin&#x02019;s deleterious effects as part of the actin scavenging system [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR82">82</xref>].</p><p id="Par27">Although unknown, it appears that VDBP levels recover during the acute phase of thermal injury [<xref ref-type="bibr" rid="CR83">83</xref>], while albumin levels may recover as early as 6&#x000a0;months [<xref ref-type="bibr" rid="CR84">84</xref>]. Due to this multiplicity of factors, interpretation of 25(OH)D levels and diagnosing vitamin D deficiency in burn patients remain challenging [<xref ref-type="bibr" rid="CR85">85</xref>].</p><p id="Par28">Vitamin D levels following severe thermal injury can also be reduced secondary to extrinsic causes including prolonged in-hospital stay (including ICU), prolonged immobilization, and lack of supplementation. Although critically ill burn patients receive oral or enteral feed supplements, current regimens have proved ineffective in replenishing vitamin D levels in the acute phase [<xref ref-type="bibr" rid="CR60">60</xref>]. Furthermore, current long-term burn management regimens involve scar management comprising mainly of sun avoidance and protection, as well as the use of pressure garments. These factors minimize sun exposure, hence reducing 25(OH)D levels. In addition, both burn scar and adjacent normal skin in burn patients exhibit subnormal conversion levels of 7-DHC to pre-D<sub>3</sub> compared to healthy individuals [<xref ref-type="bibr" rid="CR86">86</xref>]. This further potentiates vitamin D deficiency, resulting in low levels of 25(OH)D and 1,25(OH)2D for many years, at least seven, following burn injury [<xref ref-type="bibr" rid="CR87">87</xref>]. The potential causes of hypovitaminosis D following injury are summarized in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>.<fig id="Fig2"><label>Fig. 2</label><caption><p>Potential causes of vitamin D deficiency following injury</p></caption><graphic xlink:href="41038_2018_113_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec7"><title>Influence of vitamin D status on outcomes in burn patients</title><p id="Par29">Low vitamin D levels in patients with minor burns, median TBSA of 5%, have been associated with increased length of hospital stay [<xref ref-type="bibr" rid="CR88">88</xref>]. Although not statistically significant, the authors also observed higher complication rates in burn patients with low vitamin D including sepsis, pneumonia, cardiovascular complications, and graft loss [<xref ref-type="bibr" rid="CR88">88</xref>]. It is important to note that low vitamin D status in this study cohort most likely represents the population&#x02019;s pre-injury 25(OH)D levels rather than a consequence of the burn. Furthermore, this study has some limitations. Thirty percent of the cohort was admitted to the ICU with relatively minor injuries, which is unusual. No description of patient pre-morbid state or other pathologies were reported which may potentially affect vitamin D status or outcomes in general. In addition, the cohort is comprised mostly of minor partial thickness thermal injuries limiting its application in severe burns. There are no reports investigating the influence vitamin D levels on short-term outcomes of major burn patients.</p><p id="Par30">Low serum levels of vitamin D in major burn patients have shown to persist for at least 1&#x000a0;year [<xref ref-type="bibr" rid="CR83">83</xref>]. Long-term outcomes assessed include bone mineral density and leg muscle strength. Although not statistically significant, quadriceps muscle strength was lower at month 12 than the month of injury in burn patients with low vitamin D levels [<xref ref-type="bibr" rid="CR83">83</xref>]. Another long-term consequence of major thermal injury is scarring. A cross-sectional study has reported a strong negative correlation between circulating 25(OH)D levels at year 1 post-injury and subjective scar measures (modified Vancouver scar scale) [<xref ref-type="bibr" rid="CR89">89</xref>]. Both studies were limited by small sample sizes. There are no other studies investigating the influence of vitamin D on long-term outcomes of burned adult patients.</p><p id="Par31">Studies have reported increased incidence of long bone fractures among children with major burns following discharge [<xref ref-type="bibr" rid="CR90">90</xref>]. This is most likely attributed to reduced bone mineral density and vitamin D levels [<xref ref-type="bibr" rid="CR87">87</xref>, <xref ref-type="bibr" rid="CR91">91</xref>]. Vitamin D supplementation in pediatric burn patients may be beneficial in reducing fracture risk [<xref ref-type="bibr" rid="CR91">91</xref>].</p></sec><sec id="Sec8"><title>Therapeutic potential of vitamin D supplementation</title><p id="Par32">Vitamin D<sub>3</sub> supplementation may be associated with decreased mortality in the general population [<xref ref-type="bibr" rid="CR92">92</xref>]. In addition, vitamin D status has been associated with adverse outcomes in the critically ill. Despite this, there are only a few clinical studies that have evaluated vitamin D supplementation in critically ill patients. In 2014, Amrein et al. conducted the largest randomized controlled trial (RCT) to date investigating the influence of a high-dose bolus enteral vitamin D3 supplementation on outcomes of 475 critically ill medical and surgical adult patients with vitamin D deficiency (&#x02264;&#x02009;20&#x000a0;ng/mL), the VITdAL-ICU trial [<xref ref-type="bibr" rid="CR93">93</xref>]. The authors concluded that high-dose vitamin D3 did not reduce hospital length of stay, hospital mortality, or 6-month mortality [<xref ref-type="bibr" rid="CR93">93</xref>]. However, they observed lower hospital mortality following subgroup analysis of patients with severe vitamin D deficiency (&#x02264;&#x02009;12&#x000a0;ng/mL) at baseline [<xref ref-type="bibr" rid="CR93">93</xref>]. A systematic review and meta-analysis of 7 RCTs (716 patients) concluded that vitamin D administration was associated with decreased mortality in critically ill patients without serious adverse events [<xref ref-type="bibr" rid="CR94">94</xref>]. Interestingly, another recent meta-analysis of 6 RCTs (695 patients) reported no improvement on outcomes in critically ill patients supplemented with vitamin D [<xref ref-type="bibr" rid="CR95">95</xref>]. The difference between these two studies is related to inclusion and exclusion of various trials in the analysis. Other potentially important confounders in both studies are the inclusion of trials investigating cholecalciferol (vitamin D) and calcitriol (1,25(OH)<sub>2</sub>D) using various dosing regimens that were administered through different routes (enteral and intravenous). Furthermore, the VITdAL-ICU trial has a larger cohort than all the other RCTs combined and therefore has major influence in the statistical analysis. These trials are summarized in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Summary of clinical trials investigating vitamin D supplementation in critically ill patients</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>Amrein [<xref ref-type="bibr" rid="CR123">123</xref>]</td><td>2011</td><td>Austria</td><td>Single-center multidisciplinary ICU patients</td><td>25</td><td>ELISA</td><td>Single dose of cholecalciferol 540,000&#x000a0;IU</td><td>Oral</td><td>No statistical difference in assessed clinical outcome including mechanical ventilation, vasopressor dependency, hospital stay, ICU stay, and hospital mortality</td><td>None</td></tr><tr><td>Amrein [<xref ref-type="bibr" rid="CR93">93</xref>]</td><td>2014</td><td>Austria</td><td>Single-center multidisciplinary ICU patients</td><td>475</td><td>LC-MS/MS</td><td>Single dose of cholecalciferol 540,000&#x000a0;IU followed by a monthly dose of 90,000&#x000a0;IU for 5&#x000a0;months</td><td>Oral</td><td>No statistical difference in assessed clinical outcomes including hospital length of stay, hospital mortality, and 6-month mortality. Significant lower hospital mortality observed in critically severe vitamin D-deficient patients.</td><td>At month 6, 4 of 37 vitamin D-supplemented patients (11%) developed total calcium levels of &#x0003e;&#x02009;10.6&#x000a0;mg/dL vs 1 of 43 patients in placebo group</td></tr><tr><td>Leaf [<xref ref-type="bibr" rid="CR124">124</xref>]</td><td>2014</td><td>USA</td><td>Multicenter multidisciplinary ICU patients with severe sepsis and septic shock</td><td>67</td><td>LC-MS/MS</td><td>Single dose of calcitriol 2&#x000a0;&#x003bc;g</td><td>Intravenous</td><td>No influence on clinical outcome, mixed effects on inflammatory markers</td><td>None</td></tr><tr><td>Quraishi [<xref ref-type="bibr" rid="CR125">125</xref>]</td><td>2015</td><td>USA</td><td>Single-center multidisciplinary ICU patients with severe sepsis and septic shock</td><td>30</td><td>ELISA</td><td>Single dose of cholecalciferol 200,000 or 400,000&#x000a0;IU</td><td>Oral</td><td>Associated with increased cathelicidin antimicrobial peptide levels, no effect on c-reactive protein</td><td>None</td></tr><tr><td>Nair [<xref ref-type="bibr" rid="CR126">126</xref>]</td><td>2015</td><td>Australia</td><td>Single-center multidisciplinary ICU patients with systemic inflammatory response syndrome</td><td>50</td><td>LC-MS and ELISA</td><td>Single dose of cholecalciferol 150,000 or 300,000&#x000a0;IU</td><td>Oral</td><td>Associated with increased levels of cathelicidin antimicrobial peptide and reduction in pro-inflammatory cytokine interleukin 6</td><td>None</td></tr><tr><td>Han [<xref ref-type="bibr" rid="CR127">127</xref>]</td><td>2016</td><td>USA</td><td>Multicenter multidisciplinary ventilated ICU patients</td><td>30</td><td>IA and ELISA</td><td>Daily doses of cholecalciferol 50,000 or 100,000&#x000a0;IU for 5&#x000a0;days</td><td>Oral</td><td>Hospital length of stay significantly decreased</td><td>None</td></tr><tr><td>Alizadeh [<xref ref-type="bibr" rid="CR128">128</xref>]</td><td>2016</td><td>Iran</td><td>Single-center surgical ICU patients</td><td>59</td><td>ELISA</td><td>Single dose of cholecalciferol 600,000&#x000a0;IU</td><td>Intramuscular</td><td>Adiponectin, biomarker of insulin sensitivity, is significantly elevated. No effect on homoeostasis model assessment for insulin resistance and homestasis model assessment adiponectin.</td><td>Not reported</td></tr><tr><td>Han [<xref ref-type="bibr" rid="CR129">129</xref>]</td><td>2017</td><td>USA</td><td>Multicenter multidisciplinary ventilated ICU patients</td><td>30</td><td>ELISA</td><td>Daily doses of cholecalciferol 50,000 or 100,000&#x000a0;IU for 5&#x000a0;days</td><td>Oral</td><td>Associated with increasing systemic levels of mRNA expression of human cationic antimicrobial protein overtime. No effect on circulating cathelicidin and human &#x003b2;-defensin.</td><td>None</td></tr></tbody></table></table-wrap></p><p id="Par33">Rousseau et al. have shown improved muscle recovery and strength in burn patients supplemented with vitamin D and implied that vitamin D supplementation had positive effects on muscle health and may play a role during rehabilitation [<xref ref-type="bibr" rid="CR83">83</xref>]. This is the only study investigating the therapeutic potential of vitamin D following thermal injury. This lack of interventional studies could be due to a variety of reasons. First, as detailed earlier in this review, interpretation of vitamin D status has proven difficult owing to fluid shifts and low protein levels occurring in the acute response. It is assumed that binding protein levels return to normal 1&#x000a0;year post-injury, and therefore, &#x0201c;true&#x0201d; vitamin D status can be analyzed and managed [<xref ref-type="bibr" rid="CR96">96</xref>]. Second, vitamin D deficiency in burn patients is believed to be a long-term issue [<xref ref-type="bibr" rid="CR96">96</xref>], requiring a lengthy trial intervention. Third, there is still considerable debate about what vitamin D dosing regimen is optimal for supplementation studies as therapeutic benefit in relation to target serum concentrations of vitamin D remains unclear. In a recent meta-analysis of the effects of vitamin D supplementation on acute upper respiratory infection, positive response to vitamin D supplementation was only observed in patients receiving lower dose daily or weekly supplementation rather than monthly high-dose boluses of vitamin D [<xref ref-type="bibr" rid="CR97">97</xref>].</p></sec><sec id="Sec9"><title>Current knowledge gaps and limitations to progress</title><p id="Par34">Clinical trials investigating the effects of vitamin D supplementation on vitamin D status and outcomes in burn and other critically ill patients are scarce. Correction of vitamin D depletion in burn patients may prove beneficial, and further studies investigating the therapeutic potential of vitamin D should be encouraged.</p><p id="Par35">A major limitation of this type of study is the different techniques used to analyze vitamin D levels in patients and the specific vitamin D metabolites measured in each instance. Methods used to quantify the most commonly analyzed vitamin D metabolite&#x02014;25(OH)D&#x02014;include immunoassay (IA), high-performance chromatography (HPLC) or liquid chromatography tandem&#x02013;mass spectrometry (LC-MS/MS). IA measurements are subject to matrix effects, such as hemodilution, and therefore may not be as accurate [<xref ref-type="bibr" rid="CR98">98</xref>]. Additionally, several IA methods cannot distinguish between the two main forms of vitamin D (vitamin D<sub>3</sub> and vitamin D<sub>2</sub>), and cross-reactivity of vitamin D<sub>3</sub> and other vitamin D metabolites can occur [<xref ref-type="bibr" rid="CR99">99</xref>]. Vitamin D measurements by IA can also be influenced by VDBP concentration, thereby reducing its reliability [<xref ref-type="bibr" rid="CR100">100</xref>]. LC-MS/MS involves chromatographic separation and mass transition differences of molecules allowing the differentiation of analytes, thereby increasing selectivity and sensitivity.</p><p id="Par36">Due to differences in the sensitivity of each technique, the data generated may vary in accuracy and reproducibility. Therefore, analyzing and interpreting data obtained using different methodologies in various studies may not be possible. With this in mind, LC-MS/MS has proven to be the only platform offering an accurate, reliable, and reproducible method for quantification of serum 25(OH)D [<xref ref-type="bibr" rid="CR99">99</xref>], including studies involving critically ill patients [<xref ref-type="bibr" rid="CR101">101</xref>]. However, as outlined above, several other vitamin D metabolites, notably active 1,25(OH)<sub>2</sub>D, are likely to play a key role in the physiological activity of vitamin D in critically ill patients. Thus, new analytical strategies are required that incorporate simultaneous measurement of several vitamin D metabolites. LC-MS/MS protocols have been developed allowing accurate simultaneous analysis of various vitamin D metabolites in serum [<xref ref-type="bibr" rid="CR102">102</xref>]. In addition, new protocols have been developed for the measurement of &#x0201c;free&#x0201d; (VDBP-unbound) 25(OH)D [<xref ref-type="bibr" rid="CR103">103</xref>]. This bioavailable form of 25(OH)D is thought to play a crucial role in mediating immunomodulatory responses [<xref ref-type="bibr" rid="CR104">104</xref>]. In future studies of vitamin D and critical illness, it will be important to incorporate all these new technologies.</p></sec></sec><sec id="Sec10"><title>Conclusion</title><p id="Par37">Thermal injury and critical illness influence vitamin D levels. Although data are scarce, vitamin D is most frequently found to be deficient in these patients and may potentially influence short- and long-term outcomes in burn patients and the critically ill. Further studies investigating vitamin D depletion in burn patients and its influence on prognosis, via standardized methodology such as LC-MS/MS, are necessary to reach definitive conclusions and influence clinical practice. Although two major RCT trials, VIOLET (NCT03096314) and VITdAL-PICU (NCT02452762), investigating vitamin D supplementation are active, recruited patients will only be given a one-off high dose of vitamin D. More RCTs using &#x0201c;optimal&#x0201d; vitamin D regimens in well-stratified patients are required to determine the utility and risk-benefit ratio of supplementation. These studies are essential to stimulate further clinical and scientific research assessing vitamin D phenomenon in critical care settings, which would be pivotal in determining the need for change in clinical practice.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>1,25(OH)<sub>2</sub>D</term><def><p id="Par2">1&#x003b1;,25-Dihydroxyvitamin D</p></def></def-item><def-item><term>25(OH)D</term><def><p id="Par3">25-Hydroxyvitamin D</p></def></def-item><def-item><term>7-DHC</term><def><p id="Par4">7-Dehydrocholesterol</p></def></def-item><def-item><term>CYP27B1</term><def><p id="Par5">25-Hydroxyvitamin D-1&#x003b1;-hydroxylase</p></def></def-item><def-item><term>GM-CSF</term><def><p id="Par6">Granulocyte-macrophage colony-stimulating factor</p></def></def-item><def-item><term>HPLC</term><def><p id="Par7">High-performance liquid&#x000a0;chromatography</p></def></def-item><def-item><term>IA</term><def><p id="Par8">Immunoassay</p></def></def-item><def-item><term>ICU</term><def><p id="Par9">Intensive care unit</p></def></def-item><def-item><term>IL</term><def><p id="Par10">Interleukin</p></def></def-item><def-item><term>LC-MS/MS</term><def><p id="Par11">Liquid chromatography tandem&#x02013;mass spectrometry</p></def></def-item><def-item><term>VDBP</term><def><p id="Par12">Vitamin D-binding protein</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>Not applicable</p><sec id="FPar1"><title>Funding</title><p id="Par38">KAT is supported by a scholarship from the Kuwaiti Ministry of Health and Civil Service Commission, MH is supported by the National Institute of Health, NM is supported by the Scar Free Foundation, and JML is supported by the NIHR Surgical Reconstruction and Microbiology Research Centre.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par39">Not applicable</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>KAT has written the manuscript. MH, NM, and JML reviewed and wrote the manuscript. All authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p id="Par40">Not applicable</p></sec><sec id="FPar4"><title>Consent for publication</title><p id="Par41">Not applicable</p></sec><sec id="FPar5"><title>Competing interests</title><p id="Par42">The authors declare that they have no competing interests.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Vitamin D<bold>:</bold> Increasing supplement use in at-risk groups [<ext-link ext-link-type="uri" xlink:href="https://www.nice.org.uk/guidance/ph56">https://www.nice.org.uk/guidance/ph56</ext-link>. Accessed 13 May 2017].</mixed-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickerson</surname><given-names>RN</given-names></name><name><surname>Van Cleve</surname><given-names>JR</given-names></name><name><surname>Swanson</surname><given-names>JM</given-names></name><name><surname>Maish</surname><given-names>GO</given-names><suffix>3rd</suffix></name><name><surname>Minard</surname><given-names>G</given-names></name><name><surname>Croce</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Vitamin D deficiency in critically ill patients with traumatic injuries</article-title><source>Burns &#x00026; Trauma</source><year>2016</year><volume>4</volume><fpage>28</fpage><pub-id pub-id-type="pmid">27833924</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bikle</surname><given-names>DD</given-names></name></person-group><article-title>Vitamin D metabolism, mechanism of action, and clinical applications</article-title><source>Chem Biol</source><year>2014</year><volume>21</volume><issue>3</issue><fpage>319</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">24529992</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holick</surname><given-names>MF</given-names></name></person-group><article-title>Vitamin D deficiency</article-title><source>N Engl J Med</source><year>2007</year><volume>357</volume><issue>3</issue><fpage>266</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">17634462</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">Bouillon R, De Groot L, Jameson J: Vitamin D: from photosynthesis, metabolism, and action to clinical applications. Endocrinology 2001:1010&#x02013;1028.</mixed-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeLuca</surname><given-names>HF</given-names></name></person-group><article-title>Overview of general physiologic features and functions of vitamin D</article-title><source>Am J Clin Nutr</source><year>2004</year><volume>80</volume><issue>6 Suppl</issue><fpage>1689s</fpage><lpage>1696s</lpage><pub-id pub-id-type="pmid">15585789</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christakos</surname><given-names>S</given-names></name><name><surname>Dhawan</surname><given-names>P</given-names></name><name><surname>Verstuyf</surname><given-names>A</given-names></name><name><surname>Verlinden</surname><given-names>L</given-names></name><name><surname>Carmeliet</surname><given-names>G</given-names></name></person-group><article-title>Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects</article-title><source>Physiol Rev</source><year>2016</year><volume>96</volume><issue>1</issue><fpage>365</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">26681795</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlberg</surname><given-names>C</given-names></name></person-group><article-title>The physiology of vitamin D-far more than calcium and bone</article-title><source>Front Physiol</source><year>2014</year><volume>5</volume><fpage>335</fpage><pub-id pub-id-type="pmid">25228886</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Carlberg C. Molecular endocrinology of vitamin D on the epigenome level. Mol Cell Endocrinol. 2017:14&#x02013;21.</mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">The Genotype-Tissue Expression (GTEx) project [<ext-link ext-link-type="uri" xlink:href="https://gtexportal.org/home/gene/VDR">https://gtexportal.org/home/gene/VDR</ext-link>. Accessed 31 March 2017].</mixed-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>The Genotype-Tissue Expression (GTEx) project</collab></person-group><source>Nat Genet</source><year>2013</year><volume>45</volume><issue>6</issue><fpage>580</fpage><lpage>585</lpage><pub-id pub-id-type="pmid">23715323</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>Vitamin D and immune function: an overview</article-title><source>Proc Nutr Soc</source><year>2012</year><volume>71</volume><issue>1</issue><fpage>50</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">21849106</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunn</surname><given-names>JD</given-names></name><name><surname>Katz</surname><given-names>DR</given-names></name><name><surname>Barker</surname><given-names>S</given-names></name><name><surname>Fraher</surname><given-names>LJ</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name><name><surname>Hendy</surname><given-names>GN</given-names></name><etal/></person-group><article-title>Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3</article-title><source>Immunology</source><year>1986</year><volume>59</volume><issue>4</issue><fpage>479</fpage><lpage>484</lpage><pub-id pub-id-type="pmid">3026959</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boonstra</surname><given-names>A</given-names></name><name><surname>Barrat</surname><given-names>FJ</given-names></name><name><surname>Crain</surname><given-names>C</given-names></name><name><surname>Heath</surname><given-names>VL</given-names></name><name><surname>Savelkoul</surname><given-names>HF</given-names></name><name><surname>O'Garra</surname><given-names>A</given-names></name></person-group><article-title>1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells</article-title><source>J Immunol</source><year>2001</year><volume>167</volume><issue>9</issue><fpage>4974</fpage><lpage>4980</lpage><pub-id pub-id-type="pmid">11673504</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Overbergh</surname><given-names>L</given-names></name><name><surname>Decallonne</surname><given-names>B</given-names></name><name><surname>Waer</surname><given-names>M</given-names></name><name><surname>Rutgeerts</surname><given-names>O</given-names></name><name><surname>Valckx</surname><given-names>D</given-names></name><name><surname>Casteels</surname><given-names>KM</given-names></name><etal/></person-group><article-title>1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543)</article-title><source>Diabetes</source><year>2000</year><volume>49</volume><issue>8</issue><fpage>1301</fpage><lpage>1307</lpage><pub-id pub-id-type="pmid">10923629</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Kelly</surname><given-names>J</given-names></name><name><surname>Hisatake</surname><given-names>J</given-names></name><name><surname>Hisatake</surname><given-names>Y</given-names></name><name><surname>Bishop</surname><given-names>J</given-names></name><name><surname>Norman</surname><given-names>A</given-names></name><name><surname>Koeffler</surname><given-names>HP</given-names></name></person-group><article-title>Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice</article-title><source>J Clin Invest</source><year>2002</year><volume>109</volume><issue>8</issue><fpage>1091</fpage><lpage>1099</lpage><pub-id pub-id-type="pmid">11956247</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colin</surname><given-names>EM</given-names></name><name><surname>Asmawidjaja</surname><given-names>PS</given-names></name><name><surname>van Hamburg</surname><given-names>JP</given-names></name><name><surname>Mus</surname><given-names>AM</given-names></name><name><surname>van Driel</surname><given-names>M</given-names></name><name><surname>Hazes</surname><given-names>JM</given-names></name><etal/></person-group><article-title>1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis</article-title><source>Arthritis Rheum</source><year>2010</year><volume>62</volume><issue>1</issue><fpage>132</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">20039421</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniel</surname><given-names>C</given-names></name><name><surname>Sartory</surname><given-names>NA</given-names></name><name><surname>Zahn</surname><given-names>N</given-names></name><name><surname>Radeke</surname><given-names>HH</given-names></name><name><surname>Stein</surname><given-names>JM</given-names></name></person-group><article-title>Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile</article-title><source>J Pharmacol Exp Ther</source><year>2008</year><volume>324</volume><issue>1</issue><fpage>23</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">17911375</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kundu</surname><given-names>R</given-names></name><name><surname>Theodoraki</surname><given-names>A</given-names></name><name><surname>Haas</surname><given-names>CT</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chain</surname><given-names>B</given-names></name><name><surname>Kriston-Vizi</surname><given-names>J</given-names></name><etal/></person-group><article-title>Cell-type-specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes</article-title><source>Immunology</source><year>2017</year><volume>150</volume><issue>1</issue><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">27608289</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svensson</surname><given-names>D</given-names></name><name><surname>Nebel</surname><given-names>D</given-names></name><name><surname>Voss</surname><given-names>U</given-names></name><name><surname>Ekblad</surname><given-names>E</given-names></name><name><surname>Nilsson</surname><given-names>BO</given-names></name></person-group><article-title>Vitamin D-induced up-regulation of human keratinocyte cathelicidin anti-microbial peptide expression involves retinoid X receptor alpha</article-title><source>Cell Tissue Res</source><year>2016</year><volume>366</volume><issue>2</issue><fpage>353</fpage><lpage>362</lpage><pub-id pub-id-type="pmid">27357804</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>FC</given-names></name></person-group><article-title>The differential effects of 1,25-dihydroxyvitamin D3 on salmonella-induced interleukin-8 and human beta-defensin-2 in intestinal epithelial cells</article-title><source>Clin Exp Immunol</source><year>2016</year><volume>185</volume><issue>1</issue><fpage>98</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">26990648</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>WC</given-names></name><name><surname>Zheng</surname><given-names>CM</given-names></name><name><surname>Lu</surname><given-names>CL</given-names></name><name><surname>Lin</surname><given-names>YF</given-names></name><name><surname>Shyu</surname><given-names>JF</given-names></name><name><surname>Wu</surname><given-names>CC</given-names></name><etal/></person-group><article-title>Vitamin D and immune function in chronic kidney disease</article-title><source>Clinica Chimica Acta</source><year>2015</year><volume>450</volume><fpage>135</fpage><lpage>144</lpage></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alhassan Mohammed</surname><given-names>H</given-names></name><name><surname>Saboor-Yaraghi</surname><given-names>AA</given-names></name><name><surname>Mirshafiey</surname><given-names>A</given-names></name><name><surname>Vahedi</surname><given-names>H</given-names></name><name><surname>Shiri-Shahsavar</surname><given-names>MR</given-names></name></person-group><article-title>Mousavi Nasl Khameneh a: immunomodulatory and immunosuppressive roles of 1alpha,25(OH)2D3 in autoimmune diseases</article-title><source>Scand J Immunol</source><year>2017</year><volume>85</volume><issue>2</issue><fpage>95</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">27896829</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>Antibacterial effects of vitamin D</article-title><source>Nat Rev Endocrinol</source><year>2011</year><volume>7</volume><issue>6</issue><fpage>337</fpage><lpage>345</lpage><pub-id pub-id-type="pmid">21263449</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffery</surname><given-names>LE</given-names></name><name><surname>Wood</surname><given-names>AM</given-names></name><name><surname>Qureshi</surname><given-names>OS</given-names></name><name><surname>Hou</surname><given-names>TZ</given-names></name><name><surname>Gardner</surname><given-names>D</given-names></name><name><surname>Briggs</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Availability of 25-Hydroxyvitamin D3 to APCs controls the balance between regulatory and inflammatory T cell responses</article-title><source>J Immunol</source><year>2012</year><volume>189</volume><issue>11</issue><fpage>5155</fpage><lpage>5164</lpage><pub-id pub-id-type="pmid">23087405</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delanghe</surname><given-names>JR</given-names></name><name><surname>Speeckaert</surname><given-names>R</given-names></name><name><surname>Speeckaert</surname><given-names>MM</given-names></name></person-group><article-title>Behind the scenes of vitamin D binding protein: more than vitamin D binding</article-title><source>Best Pract Res Clin Endocrinol Metab</source><year>2015</year><volume>29</volume><issue>5</issue><fpage>773</fpage><lpage>786</lpage><pub-id pub-id-type="pmid">26522461</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrer</surname><given-names>R</given-names></name><name><surname>Mateu</surname><given-names>X</given-names></name><name><surname>Maseda</surname><given-names>E</given-names></name><name><surname>Yebenes</surname><given-names>JC</given-names></name><name><surname>Aldecoa</surname><given-names>C</given-names></name><name><surname>De Haro</surname><given-names>C</given-names></name><etal/></person-group><article-title>Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients</article-title><source>Expert Rev Clin Pharmacol</source><year>2018</year><volume>11</volume><issue>2</issue><fpage>125</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">29219627</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Vincent JL, De Backer D, Wiedermann CJ: Fluid management in sepsis: the potential beneficial effects of albumin. J Crit Care 2016, 35:161&#x02013;167.</mixed-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullins</surname><given-names>PM</given-names></name><name><surname>Goyal</surname><given-names>M</given-names></name><name><surname>Pines</surname><given-names>JM</given-names></name></person-group><article-title>National growth in intensive care unit admissions from emergency departments in the United States from 2002 to 2009</article-title><source>Acad Emerg Med Off J Soc Acad Emerg Med</source><year>2013</year><volume>20</volume><issue>5</issue><fpage>479</fpage><lpage>486</lpage></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amrein</surname><given-names>K</given-names></name><name><surname>Zajic</surname><given-names>P</given-names></name><name><surname>Schnedl</surname><given-names>C</given-names></name><name><surname>Waltensdorfer</surname><given-names>A</given-names></name><name><surname>Fruhwald</surname><given-names>S</given-names></name><name><surname>Holl</surname><given-names>A</given-names></name><etal/></person-group><article-title>Vitamin D status and its association with season, hospital and sepsis mortality in critical illness</article-title><source>Crit Care</source><year>2014</year><volume>18</volume><issue>2</issue><fpage>R47</fpage><pub-id pub-id-type="pmid">24661739</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="other">Aygencel G, Turkoglu M, Tuncel AF, Cand&#x00131;r BA, Bildac&#x00131; YD, Pasaoglu H. Is vitamin D insufficiency associated with mortality of critically ill patients? Crit Care Res Prac. 2013;2013</mixed-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>P</given-names></name><name><surname>Eisman</surname><given-names>JA</given-names></name><name><surname>Center</surname><given-names>JR</given-names></name></person-group><article-title>Vitamin D deficiency in critically ill patients</article-title><source>N Engl J Med</source><year>2009</year><volume>360</volume><issue>18</issue><fpage>1912</fpage><lpage>1914</lpage><pub-id pub-id-type="pmid">19403914</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>P</given-names></name><name><surname>Lee</surname><given-names>P</given-names></name><name><surname>Reynolds</surname><given-names>C</given-names></name><name><surname>Nguyen</surname><given-names>ND</given-names></name><name><surname>Myburgh</surname><given-names>J</given-names></name><name><surname>Eisman</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Significant perturbation of vitamin D-parathyroid-calcium axis and adverse clinical outcomes in critically ill patients</article-title><source>Intensive Care Med</source><year>2013</year><volume>39</volume><issue>2</issue><fpage>267</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">23064465</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alizadeh</surname><given-names>N</given-names></name><name><surname>Khalili</surname><given-names>H</given-names></name><name><surname>Mohammadi</surname><given-names>M</given-names></name><name><surname>Abdollahi</surname><given-names>A</given-names></name></person-group><article-title>Serum vitamin D levels at admission predict the length of intensive care unit stay but not in-hospital mortality of critically ill surgical patients</article-title><source>J Res Pharma Prac</source><year>2015</year><volume>4</volume><issue>4</issue><fpage>193</fpage><lpage>198</lpage></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Qin</surname><given-names>H</given-names></name><etal/></person-group><article-title>Changes in the calcium-parathyroid hormone-vitamin d axis and prognosis for critically ill patients: a prospective observational study</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>9</issue><fpage>e75441</fpage><pub-id pub-id-type="pmid">24073266</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghashut</surname><given-names>RA</given-names></name><name><surname>Talwar</surname><given-names>D</given-names></name><name><surname>Kinsella</surname><given-names>J</given-names></name><name><surname>Duncan</surname><given-names>A</given-names></name><name><surname>McMillan</surname><given-names>DC</given-names></name></person-group><article-title>The effect of the systemic inflammatory response on plasma vitamin 25 (OH) D concentrations adjusted for albumin</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>3</issue><fpage>e92614</fpage><pub-id pub-id-type="pmid">24667823</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>P</given-names></name><name><surname>Nair</surname><given-names>P</given-names></name><name><surname>Eisman</surname><given-names>JA</given-names></name><name><surname>Center</surname><given-names>JR</given-names></name></person-group><article-title>Vitamin D deficiency in the intensive care unit: an invisible accomplice to morbidity and mortality?</article-title><source>Intensive Care Med</source><year>2009</year><volume>35</volume><issue>12</issue><fpage>2028</fpage><lpage>2032</lpage><pub-id pub-id-type="pmid">19756497</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schrumpf</surname><given-names>JA</given-names></name><name><surname>Amatngalim</surname><given-names>GD</given-names></name><name><surname>Veldkamp</surname><given-names>JB</given-names></name><name><surname>Verhoosel</surname><given-names>RM</given-names></name><name><surname>Ninaber</surname><given-names>DK</given-names></name><name><surname>Ordonez</surname><given-names>SR</given-names></name><etal/></person-group><article-title>Proinflammatory cytokines impair vitamin D-induced host defense in cultured airway epithelial cells</article-title><source>Am J Respir Cell Mol Biol</source><year>2017</year><volume>56</volume><issue>6</issue><fpage>749</fpage><lpage>761</lpage><pub-id pub-id-type="pmid">28231019</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>A</given-names></name><name><surname>Ochola</surname><given-names>J</given-names></name><name><surname>Mundy</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>M</given-names></name><name><surname>Kruger</surname><given-names>P</given-names></name><name><surname>Duncan</surname><given-names>E</given-names></name><etal/></person-group><article-title>Acute fluid shifts influence the assessment of serum vitamin D status in critically ill patients</article-title><source>Critical care</source><year>2010</year><volume>14</volume><issue>6</issue><fpage>R216</fpage><pub-id pub-id-type="pmid">21110839</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>D</given-names></name><name><surname>Toole</surname><given-names>BJ</given-names></name><name><surname>Knox</surname><given-names>S</given-names></name><name><surname>Talwar</surname><given-names>D</given-names></name><name><surname>Harten</surname><given-names>J</given-names></name><name><surname>O'Reilly</surname><given-names>DS</given-names></name><etal/></person-group><article-title>The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty</article-title><source>Am J Clin Nutr</source><year>2011</year><volume>93</volume><issue>5</issue><fpage>1006</fpage><lpage>1011</lpage><pub-id pub-id-type="pmid">21411617</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahl</surname><given-names>B</given-names></name><name><surname>Schiodt</surname><given-names>FV</given-names></name><name><surname>Kiaer</surname><given-names>T</given-names></name><name><surname>Ott</surname><given-names>P</given-names></name><name><surname>Bondesen</surname><given-names>S</given-names></name><name><surname>Tygstrup</surname><given-names>N</given-names></name></person-group><article-title>Serum Gc-globulin in the early course of multiple trauma</article-title><source>Crit Care Med</source><year>1998</year><volume>26</volume><issue>2</issue><fpage>285</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">9468166</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldron</surname><given-names>JL</given-names></name><name><surname>Ashby</surname><given-names>HL</given-names></name><name><surname>Cornes</surname><given-names>MP</given-names></name><name><surname>Bechervaise</surname><given-names>J</given-names></name><name><surname>Razavi</surname><given-names>C</given-names></name><name><surname>Thomas</surname><given-names>OL</given-names></name><etal/></person-group><article-title>Vitamin D: a negative acute phase reactant</article-title><source>J Clin Pathol</source><year>2013</year><volume>66</volume><issue>7</issue><fpage>620</fpage><lpage>622</lpage><pub-id pub-id-type="pmid">23454726</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amrein</surname><given-names>K</given-names></name><name><surname>Christopher</surname><given-names>KB</given-names></name><name><surname>McNally</surname><given-names>JD</given-names></name></person-group><article-title>Understanding vitamin D deficiency in intensive care patients</article-title><source>Intensive Care Med</source><year>2015</year><volume>41</volume><issue>11</issue><fpage>1961</fpage><lpage>1964</lpage><pub-id pub-id-type="pmid">26142054</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moromizato</surname><given-names>T</given-names></name><name><surname>Litonjua</surname><given-names>AA</given-names></name><name><surname>Braun</surname><given-names>AB</given-names></name><name><surname>Gibbons</surname><given-names>FK</given-names></name><name><surname>Giovannucci</surname><given-names>E</given-names></name><name><surname>Christopher</surname><given-names>KB</given-names></name></person-group><article-title>Association of low serum 25-hydroxyvitamin D levels and sepsis in the critically ill</article-title><source>Crit Care Med</source><year>2014</year><volume>42</volume><issue>1</issue><fpage>97</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">23982028</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jovanovich</surname><given-names>AJ</given-names></name><name><surname>Ginde</surname><given-names>AA</given-names></name><name><surname>Holmen</surname><given-names>J</given-names></name><name><surname>Jablonski</surname><given-names>K</given-names></name><name><surname>Allyn</surname><given-names>RL</given-names></name><name><surname>Kendrick</surname><given-names>J</given-names></name><etal/></person-group><article-title>Vitamin D level and risk of community-acquired pneumonia and sepsis</article-title><source>Nutrients</source><year>2014</year><volume>6</volume><issue>6</issue><fpage>2196</fpage><lpage>2205</lpage><pub-id pub-id-type="pmid">24918697</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>AB</given-names></name><name><surname>Litonjua</surname><given-names>AA</given-names></name><name><surname>Moromizato</surname><given-names>T</given-names></name><name><surname>Gibbons</surname><given-names>FK</given-names></name><name><surname>Giovannucci</surname><given-names>E</given-names></name><name><surname>Christopher</surname><given-names>KB</given-names></name></person-group><article-title>Association of low serum 25-hydroxyvitamin D levels and acute kidney injury in the critically ill</article-title><source>Crit Care Med</source><year>2012</year><volume>40</volume><issue>12</issue><fpage>3170</fpage><lpage>3179</lpage><pub-id pub-id-type="pmid">22975885</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thickett</surname><given-names>DR</given-names></name><name><surname>Moromizato</surname><given-names>T</given-names></name><name><surname>Litonjua</surname><given-names>AA</given-names></name><name><surname>Amrein</surname><given-names>K</given-names></name><name><surname>Quraishi</surname><given-names>SA</given-names></name><name><surname>Lee-Sarwar</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Association between prehospital vitamin D status and incident acute respiratory failure in critically ill patients: a retrospective cohort study</article-title><source>BMJ Open Resp Res</source><year>2015</year><volume>2</volume><issue>1</issue><fpage>e000074</fpage><pub-id pub-id-type="pmid">26113982</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venkatram</surname><given-names>S</given-names></name><name><surname>Chilimuri</surname><given-names>S</given-names></name><name><surname>Adrish</surname><given-names>M</given-names></name><name><surname>Salako</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>M</given-names></name><name><surname>Diaz-Fuentes</surname><given-names>G</given-names></name></person-group><article-title>Vitamin D deficiency is associated with mortality in the medical intensive care unit</article-title><source>Critical care</source><year>2011</year><volume>15</volume><issue>6</issue><fpage>R292</fpage><pub-id pub-id-type="pmid">22152332</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Luo</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>H</given-names></name><etal/></person-group><article-title>Association of vitamin D status of septic patients in intensive care units with altered procalcitonin levels and mortality</article-title><source>J Clin Endocrinol Metab</source><year>2015</year><volume>100</volume><issue>2</issue><fpage>516</fpage><lpage>523</lpage><pub-id pub-id-type="pmid">25423563</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>LR</given-names></name><name><surname>Ahmed</surname><given-names>Y</given-names></name><name><surname>Wilson</surname><given-names>KL</given-names></name><name><surname>Griggs</surname><given-names>DD</given-names></name><name><surname>Danner</surname><given-names>OK</given-names></name></person-group><article-title>Worsening severity of vitamin D deficiency is associated with increased length of stay, surgical intensive care unit cost, and mortality rate in surgical intensive care unit patients</article-title><source>Am J Surg</source><year>2012</year><volume>204</volume><issue>1</issue><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">22325335</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>L</given-names></name><name><surname>Zimmerman</surname><given-names>LH</given-names></name><name><surname>McNorton</surname><given-names>K</given-names></name><name><surname>Dolman</surname><given-names>M</given-names></name><name><surname>Tyburski</surname><given-names>J</given-names></name><name><surname>Baylor</surname><given-names>A</given-names></name><etal/></person-group><article-title>Effects of vitamin D deficiency in critically ill surgical patients</article-title><source>Am J Surg</source><year>2012</year><volume>203</volume><issue>3</issue><fpage>379</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">22206852</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quraishi</surname><given-names>SA</given-names></name><name><surname>Bittner</surname><given-names>EA</given-names></name><name><surname>Blum</surname><given-names>L</given-names></name><name><surname>McCarthy</surname><given-names>CM</given-names></name><name><surname>Bhan</surname><given-names>I</given-names></name><name><surname>Camargo</surname><given-names>CA</given-names><suffix>Jr</suffix></name></person-group><article-title>Prospective study of vitamin D status at initiation of care in critically ill surgical patients and risk of 90-day mortality</article-title><source>Crit Care Med</source><year>2014</year><volume>42</volume><issue>6</issue><fpage>1365</fpage><lpage>1371</lpage><pub-id pub-id-type="pmid">24557421</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quraishi</surname><given-names>SA</given-names></name><name><surname>McCarthy</surname><given-names>C</given-names></name><name><surname>Blum</surname><given-names>L</given-names></name><name><surname>Cobb</surname><given-names>JP</given-names></name><name><surname>Camargo</surname><given-names>CA</given-names><suffix>Jr</suffix></name></person-group><article-title>Plasma 25-Hydroxyvitamin D levels at initiation of care and duration of mechanical ventilation in critically ill surgical patients</article-title><source>JPEN J Parenter Enteral Nutr</source><year>2016</year><volume>40</volume><issue>2</issue><fpage>273</fpage><lpage>278</lpage><pub-id pub-id-type="pmid">25564428</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ala-Kokko</surname><given-names>TI</given-names></name><name><surname>Mutt</surname><given-names>SJ</given-names></name><name><surname>Nisula</surname><given-names>S</given-names></name><name><surname>Koskenkari</surname><given-names>J</given-names></name><name><surname>Liisanantti</surname><given-names>J</given-names></name><name><surname>Ohtonen</surname><given-names>P</given-names></name><etal/></person-group><article-title>Vitamin D deficiency at admission is not associated with 90-day mortality in patients with severe sepsis or septic shock: observational FINNAKI cohort study</article-title><source>Ann Med</source><year>2016</year><volume>48</volume><issue>1&#x02013;2</issue><fpage>67</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">26800186</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="other">Ratzinger F, Haslacher H, Stadlberger M, Schmidt RLJ, Oberm&#x000fc;ller M, Schmetterer KG, et al. 25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study. Sci Rep. 2017;7</mixed-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vosoughi</surname><given-names>N</given-names></name><name><surname>Kashefi</surname><given-names>P</given-names></name><name><surname>Abbasi</surname><given-names>B</given-names></name><name><surname>Feizi</surname><given-names>A</given-names></name><name><surname>Askari</surname><given-names>G</given-names></name><name><surname>Azadbakht</surname><given-names>L</given-names></name></person-group><article-title>The relationship between vitamin D, clinical outcomes and mortality rate in ICU patients: a prospective observational study</article-title><source>J Res Med Sci</source><year>2016</year><volume>21</volume><fpage>75</fpage><pub-id pub-id-type="pmid">27904620</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YP</given-names></name><name><surname>Wan</surname><given-names>YD</given-names></name><name><surname>Sun</surname><given-names>TW</given-names></name><name><surname>Kan</surname><given-names>QC</given-names></name><name><surname>Wang</surname><given-names>LX</given-names></name></person-group><article-title>Association between vitamin D deficiency and mortality in critically ill adult patients: a meta-analysis of cohort studies</article-title><source>Critical care</source><year>2014</year><volume>18</volume><issue>6</issue><fpage>684</fpage><pub-id pub-id-type="pmid">25498305</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Haan</surname><given-names>K</given-names></name><name><surname>Groeneveld</surname><given-names>AB</given-names></name><name><surname>de Geus</surname><given-names>HR</given-names></name><name><surname>Egal</surname><given-names>M</given-names></name><name><surname>Struijs</surname><given-names>A</given-names></name></person-group><article-title>Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis</article-title><source>Critical care</source><year>2014</year><volume>18</volume><issue>6</issue><fpage>660</fpage><pub-id pub-id-type="pmid">25475621</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upala</surname><given-names>S</given-names></name><name><surname>Sanguankeo</surname><given-names>A</given-names></name><name><surname>Permpalung</surname><given-names>N</given-names></name></person-group><article-title>Significant association between vitamin D deficiency and sepsis: a systematic review and meta-analysis</article-title><source>BMC Anesthesiol</source><year>2015</year><volume>15</volume><fpage>84</fpage><pub-id pub-id-type="pmid">26041306</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rousseau</surname><given-names>AF</given-names></name><name><surname>Damas</surname><given-names>P</given-names></name><name><surname>Ledoux</surname><given-names>D</given-names></name><name><surname>Cavalier</surname><given-names>E</given-names></name></person-group><article-title>Effect of cholecalciferol recommended daily allowances on vitamin D status and fibroblast growth factor-23: an observational study in acute burn patients</article-title><source>Burns</source><year>2014</year><volume>40</volume><issue>5</issue><fpage>865</fpage><lpage>870</lpage><pub-id pub-id-type="pmid">24462294</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="other">Rousseau AF, Damas P, Ledoux D, Lukas P, Carlisi A, Le Goff C <italic>et al</italic>: Vitamin D status after a high dose of cholecalciferol in healthy and burn subjects. Burns 2015, 41(5):1028&#x02013;1034.</mixed-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>W</given-names></name><name><surname>Mindrinos</surname><given-names>MN</given-names></name><name><surname>Seok</surname><given-names>J</given-names></name><name><surname>Cuschieri</surname><given-names>J</given-names></name><name><surname>Cuenca</surname><given-names>AG</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name><etal/></person-group><article-title>A genomic storm in critically injured humans</article-title><source>J Exp Med</source><year>2011</year><volume>208</volume><issue>13</issue><fpage>2581</fpage><lpage>2590</lpage><pub-id pub-id-type="pmid">22110166</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="other">Hampson P, Dinsdale RJ, Wearn CM, Bamford AL, Bishop JR, Hazeldine J, et al. Neutrophil dysfunction, immature granulocytes, and cell-free DNA are early biomarkers of Sepsis in burn-injured patients: a prospective observational cohort study. Ann Surg. 2016;</mixed-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeschke</surname><given-names>MG</given-names></name><name><surname>Patsouris</surname><given-names>D</given-names></name><name><surname>Stanojcic</surname><given-names>M</given-names></name><name><surname>Abdullahi</surname><given-names>A</given-names></name><name><surname>Rehou</surname><given-names>S</given-names></name><name><surname>Pinto</surname><given-names>R</given-names></name><etal/></person-group><article-title>Pathophysiologic response to burns in the elderly</article-title><source>EBioMedicine</source><year>2015</year><volume>2</volume><issue>10</issue><fpage>1536</fpage><lpage>1548</lpage><pub-id pub-id-type="pmid">26629550</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haik</surname><given-names>J</given-names></name><name><surname>Nardini</surname><given-names>G</given-names></name><name><surname>Goldman</surname><given-names>N</given-names></name><name><surname>Galore-Haskel</surname><given-names>G</given-names></name><name><surname>Harats</surname><given-names>M</given-names></name><name><surname>Zilinsky</surname><given-names>I</given-names></name><etal/></person-group><article-title>Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><issue>3</issue><fpage>2220</fpage><lpage>2228</lpage><pub-id pub-id-type="pmid">26745675</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finnerty</surname><given-names>CC</given-names></name><name><surname>Jeschke</surname><given-names>MG</given-names></name><name><surname>Herndon</surname><given-names>DN</given-names></name><name><surname>Gamelli</surname><given-names>R</given-names></name><name><surname>Gibran</surname><given-names>N</given-names></name><name><surname>Klein</surname><given-names>M</given-names></name><etal/></person-group><article-title>Temporal cytokine profiles in severely burned patients: a comparison of adults and children</article-title><source>Mol Med Mass</source><year>2008</year><volume>14</volume><issue>9&#x02013;10</issue><fpage>553</fpage><lpage>560</lpage></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeschke</surname><given-names>MG</given-names></name><name><surname>Gauglitz</surname><given-names>GG</given-names></name><name><surname>Kulp</surname><given-names>GA</given-names></name><name><surname>Finnerty</surname><given-names>CC</given-names></name><name><surname>Williams</surname><given-names>FN</given-names></name><name><surname>Kraft</surname><given-names>R</given-names></name><etal/></person-group><article-title>Long-term persistance of the pathophysiologic response to severe burn injury</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><issue>7</issue><fpage>e21245</fpage><pub-id pub-id-type="pmid">21789167</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfe</surname><given-names>RR</given-names></name></person-group><article-title>Review: acute versus chronic response to burn injury</article-title><source>Circ Shock</source><year>1981</year><volume>8</volume><issue>1</issue><fpage>105</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">7016359</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otterbein</surname><given-names>LR</given-names></name><name><surname>Cosio</surname><given-names>C</given-names></name><name><surname>Graceffa</surname><given-names>P</given-names></name><name><surname>Dominguez</surname><given-names>R</given-names></name></person-group><article-title>Crystal structures of the vitamin D-binding protein and its complex with actin: structural basis of the actin-scavenger system</article-title><source>Proc Natl Acad Sci U S A</source><year>2002</year><volume>99</volume><issue>12</issue><fpage>8003</fpage><lpage>8008</lpage><pub-id pub-id-type="pmid">12048248</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>P</given-names></name><name><surname>Abdullahi</surname><given-names>A</given-names></name><name><surname>Stanojcic</surname><given-names>M</given-names></name><name><surname>Patsouris</surname><given-names>D</given-names></name><name><surname>Jeschke</surname><given-names>MG</given-names></name></person-group><article-title>Lipidomic analysis enables prediction of clinical outcomes in burn patients</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>38707</fpage><pub-id pub-id-type="pmid">27982130</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patsouris</surname><given-names>D</given-names></name></person-group><article-title>Burn Induces Browning of the Subcutaneous White Adipose Tissue in Mice and Humans</article-title><source>Cell Rep</source><year>2015</year><volume>13</volume><issue>8</issue><fpage>1538</fpage><lpage>1544</lpage><pub-id pub-id-type="pmid">26586436</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeschke</surname><given-names>MG</given-names></name><name><surname>Finnerty</surname><given-names>CC</given-names></name><name><surname>Herndon</surname><given-names>DN</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Boehning</surname><given-names>D</given-names></name><name><surname>Tompkins</surname><given-names>RG</given-names></name><etal/></person-group><article-title>Severe injury is associated with insulin resistance, endoplasmic reticulum stress response, and unfolded protein response</article-title><source>Ann Surg</source><year>2012</year><volume>255</volume><issue>2</issue><fpage>370</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">22241293</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>T</given-names></name><name><surname>Herndon</surname><given-names>DN</given-names></name><name><surname>Porter</surname><given-names>C</given-names></name><name><surname>Chondronikola</surname><given-names>M</given-names></name><name><surname>Chaidemenou</surname><given-names>A</given-names></name><name><surname>Abdelrahman</surname><given-names>DR</given-names></name><etal/></person-group><article-title>Skeletal muscle protein breakdown remains elevated in pediatric burn survivors up to one-year post-injury</article-title><source>Shock</source><year>2015</year><volume>44</volume><issue>5</issue><fpage>397</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">26263438</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeschke</surname><given-names>MG</given-names></name><name><surname>Chinkes</surname><given-names>DL</given-names></name><name><surname>Finnerty</surname><given-names>CC</given-names></name><name><surname>Kulp</surname><given-names>G</given-names></name><name><surname>Suman</surname><given-names>OE</given-names></name><name><surname>Norbury</surname><given-names>WB</given-names></name><etal/></person-group><article-title>Pathophysiologic response to severe burn injury</article-title><source>Ann Surg</source><year>2008</year><volume>248</volume><issue>3</issue><fpage>387</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">18791359</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cope</surname><given-names>O</given-names></name><name><surname>Moore</surname><given-names>FD</given-names></name></person-group><article-title>The redistribution of body water and the fluid therapy of the burned patient</article-title><source>Ann Surg</source><year>1947</year><volume>126</volume><issue>6</issue><fpage>1010</fpage><lpage>1045</lpage><pub-id pub-id-type="pmid">17859039</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lantos</surname><given-names>J</given-names></name><name><surname>Foldi</surname><given-names>V</given-names></name><name><surname>Roth</surname><given-names>E</given-names></name><name><surname>Weber</surname><given-names>G</given-names></name><name><surname>Bogar</surname><given-names>L</given-names></name><name><surname>Csontos</surname><given-names>C</given-names></name></person-group><article-title>Burn trauma induces early HMGB1 release in patients: its correlation with cytokines</article-title><source>Shock</source><year>2010</year><volume>33</volume><issue>6</issue><fpage>562</fpage><lpage>567</lpage><pub-id pub-id-type="pmid">19997053</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>WJ</given-names></name><name><surname>Petritis</surname><given-names>BO</given-names></name><name><surname>Kaushal</surname><given-names>A</given-names></name><name><surname>Finnerty</surname><given-names>CC</given-names></name><name><surname>Jeschke</surname><given-names>MG</given-names></name><name><surname>Monroe</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Plasma proteome response to severe burn injury revealed by (18)O-labeled &#x0201c;universal&#x0201d; reference-based quantitative proteomics</article-title><source>J Proteome Res</source><year>2010</year><volume>9</volume><issue>9</issue><fpage>4779</fpage><lpage>4789</lpage><pub-id pub-id-type="pmid">20698492</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arturson</surname><given-names>G</given-names></name></person-group><article-title>Microvascular permeability to macromolecules in thermal injury</article-title><source>Acta Physiol Scand Suppl</source><year>1979</year><volume>463</volume><fpage>111</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">89784</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>HF</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Lineaweaver</surname><given-names>WC</given-names></name></person-group><article-title>History and advancement of burn treatments</article-title><source>Ann Plast Surg</source><year>2017</year><volume>78</volume><issue>2 Suppl 1</issue><fpage>S2</fpage><lpage>s8</lpage><pub-id pub-id-type="pmid">28079548</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentile</surname><given-names>LF</given-names></name><name><surname>Cuenca</surname><given-names>AG</given-names></name><name><surname>Efron</surname><given-names>PA</given-names></name><name><surname>Ang</surname><given-names>D</given-names></name><name><surname>McKinley</surname><given-names>BA</given-names></name><name><surname>Moldawer</surname><given-names>LL</given-names></name><etal/></person-group><article-title>Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care</article-title><source>J Trauma Acute Care Surg</source><year>2012</year><volume>72</volume><issue>6</issue><fpage>1491</fpage><lpage>1501</lpage><pub-id pub-id-type="pmid">22695412</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlachou</surname><given-names>E</given-names></name><name><surname>Gosling</surname><given-names>P</given-names></name><name><surname>Moiemen</surname><given-names>NS</given-names></name></person-group><article-title>Microalbuminuria: a marker of endothelial dysfunction in thermal injury</article-title><source>Burns</source><year>2006</year><volume>32</volume><issue>8</issue><fpage>1009</fpage><lpage>1016</lpage><pub-id pub-id-type="pmid">16884855</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>WM</given-names></name><name><surname>Galbraith</surname><given-names>RM</given-names></name></person-group><article-title>The extracellular actin-scavenger system and actin toxicity</article-title><source>N Engl J Med</source><year>1992</year><volume>326</volume><issue>20</issue><fpage>1335</fpage><lpage>1341</lpage><pub-id pub-id-type="pmid">1314333</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rousseau</surname><given-names>AF</given-names></name><name><surname>Foidart-Desalle</surname><given-names>M</given-names></name><name><surname>Ledoux</surname><given-names>D</given-names></name><name><surname>Remy</surname><given-names>C</given-names></name><name><surname>Croisier</surname><given-names>JL</given-names></name><name><surname>Damas</surname><given-names>P</given-names></name><etal/></person-group><article-title>Effects of cholecalciferol supplementation and optimized calcium intakes on vitamin D status, muscle strength and bone health: a one-year pilot randomized controlled trial in adults with severe burns</article-title><source>Burns</source><year>2015</year><volume>41</volume><issue>2</issue><fpage>317</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">25239849</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>GL</given-names></name><name><surname>Herndon</surname><given-names>DN</given-names></name><name><surname>Chen</surname><given-names>TC</given-names></name><name><surname>Kulp</surname><given-names>G</given-names></name><name><surname>Holick</surname><given-names>MF</given-names></name></person-group><article-title>Standard multivitamin supplementation does not improve vitamin D insufficiency after burns</article-title><source>J Bone Miner Metab</source><year>2009</year><volume>27</volume><issue>4</issue><fpage>502</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">19291356</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quraishi</surname><given-names>SA</given-names></name><name><surname>Camargo</surname><given-names>CA</given-names><suffix>Jr</suffix></name></person-group><article-title>Vitamin D in acute stress and critical illness</article-title><source>Curr Opin Clin Nutr Metab Care</source><year>2012</year><volume>15</volume><issue>6</issue><fpage>625</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">23075939</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>GL</given-names></name><name><surname>Chen</surname><given-names>TC</given-names></name><name><surname>Holick</surname><given-names>MF</given-names></name><name><surname>Langman</surname><given-names>CB</given-names></name><name><surname>Price</surname><given-names>H</given-names></name><name><surname>Celis</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Synthesis of vitamin D in skin after burns</article-title><source>Lancet</source><year>2004</year><volume>363</volume><issue>9405</issue><fpage>291</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">14751703</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>GL</given-names></name><name><surname>Langman</surname><given-names>CB</given-names></name><name><surname>Herndon</surname><given-names>DN</given-names></name></person-group><article-title>Vitamin D depletion following burn injury in children: a possible factor in post-burn osteopenia</article-title><source>J Trauma</source><year>2002</year><volume>52</volume><issue>2</issue><fpage>346</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">11834999</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blay</surname><given-names>B</given-names></name><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Coffey</surname><given-names>R</given-names></name><name><surname>Jones</surname><given-names>L</given-names></name><name><surname>Murphy</surname><given-names>CV</given-names></name></person-group><article-title>Low vitamin D level on admission for burn injury is associated with increased length of stay</article-title><source>J Burn Care Res</source><year>2017</year><volume>38</volume><issue>1</issue><fpage>e8</fpage><lpage>e13</lpage><pub-id pub-id-type="pmid">27679960</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terzi</surname><given-names>R</given-names></name><name><surname>Guven</surname><given-names>M</given-names></name></person-group><article-title>Bone mineral density after burn injury and its relation to the characteristics of scar tissue</article-title><source>J Burn Care Res</source><year>2016</year><volume>37</volume><issue>3</issue><fpage>e263</fpage><lpage>e267</lpage><pub-id pub-id-type="pmid">25882515</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayes</surname><given-names>T</given-names></name><name><surname>Gottschlich</surname><given-names>M</given-names></name><name><surname>Scanlon</surname><given-names>J</given-names></name><name><surname>Warden</surname><given-names>GD</given-names></name></person-group><article-title>Four-year review of burns as an etiologic factor in the development of long bone fractures in pediatric patients</article-title><source>J Burn Care Rehabil</source><year>2003</year><volume>24</volume><issue>5</issue><fpage>279</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">14501395</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayes</surname><given-names>T</given-names></name><name><surname>Gottschlich</surname><given-names>MM</given-names></name><name><surname>Khoury</surname><given-names>J</given-names></name><name><surname>Kagan</surname><given-names>RJ</given-names></name></person-group><article-title>Investigation of bone health subsequent to vitamin D supplementation in children following burn injury</article-title><source>Nutr Clin Pract</source><year>2015</year><volume>30</volume><issue>6</issue><fpage>830</fpage><lpage>837</lpage><pub-id pub-id-type="pmid">26024678</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjelakovic</surname><given-names>G</given-names></name><name><surname>Gluud</surname><given-names>LL</given-names></name><name><surname>Nikolova</surname><given-names>D</given-names></name><name><surname>Whitfield</surname><given-names>K</given-names></name><name><surname>Wetterslev</surname><given-names>J</given-names></name><name><surname>Simonetti</surname><given-names>RG</given-names></name><etal/></person-group><article-title>Vitamin D supplementation for prevention of mortality in adults</article-title><source>Cochrane Data System Rev</source><year>2014</year><volume>1</volume><fpage>Cd007470</fpage></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amrein</surname><given-names>K</given-names></name><name><surname>Schnedl</surname><given-names>C</given-names></name><name><surname>Holl</surname><given-names>A</given-names></name><name><surname>Riedl</surname><given-names>R</given-names></name><name><surname>Christopher</surname><given-names>KB</given-names></name><name><surname>Pachler</surname><given-names>C</given-names></name><etal/></person-group><article-title>Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial</article-title><source>JAMA</source><year>2014</year><volume>312</volume><issue>15</issue><fpage>1520</fpage><lpage>1530</lpage><pub-id pub-id-type="pmid">25268295</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Putzu</surname><given-names>A</given-names></name><name><surname>Belletti</surname><given-names>A</given-names></name><name><surname>Cassina</surname><given-names>T</given-names></name><name><surname>Clivio</surname><given-names>S</given-names></name><name><surname>Monti</surname><given-names>G</given-names></name><name><surname>Zangrillo</surname><given-names>A</given-names></name><etal/></person-group><article-title>Vitamin D and outcomes in adult critically ill patients. A systematic review and meta-analysis of randomized trials</article-title><source>J Crit Care</source><year>2017</year><volume>38</volume><fpage>109</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">27883968</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Langlois</surname><given-names>PL</given-names></name><name><surname>Szwec</surname><given-names>C</given-names></name><name><surname>D'Aragon</surname><given-names>F</given-names></name><name><surname>Heyland</surname><given-names>DK</given-names></name><name><surname>Manzanares</surname><given-names>W</given-names></name></person-group><source>Vitamin D supplementation in the critically ill: a systematic review and meta-analysis</source><year>2017</year><publisher-loc>Edinburgh</publisher-loc><publisher-name>Clinical nutrition</publisher-name></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>GL</given-names></name></person-group><article-title>Should we give vitamin D to severe burns patients? The conundrum</article-title><source>Burns</source><year>2014</year><volume>40</volume><issue>1</issue><fpage>169</fpage><pub-id pub-id-type="pmid">24011706</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martineau</surname><given-names>AR</given-names></name><name><surname>Jolliffe</surname><given-names>DA</given-names></name><name><surname>Hooper</surname><given-names>RL</given-names></name><name><surname>Greenberg</surname><given-names>L</given-names></name><name><surname>Aloia</surname><given-names>JF</given-names></name><name><surname>Bergman</surname><given-names>P</given-names></name><etal/></person-group><article-title>Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data</article-title><source>BMJ Clin Res</source><year>2017</year><volume>i6583</volume><fpage>356</fpage></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Khoury</surname><given-names>JM</given-names></name><name><surname>Reineks</surname><given-names>EZ</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name></person-group><article-title>Progress of liquid chromatography-mass spectrometry in measurement of vitamin D metabolites and analogues</article-title><source>Clin Biochem</source><year>2011</year><volume>44</volume><issue>1</issue><fpage>66</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">20493831</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>AE</given-names></name><name><surname>Keevil</surname><given-names>B</given-names></name><name><surname>Huhtaniemi</surname><given-names>IT</given-names></name></person-group><article-title>Mass spectrometry and immunoassay: how to measure steroid hormones today and tomorrow</article-title><source>Eur J Endocrinol</source><year>2015</year><volume>173</volume><issue>2</issue><fpage>D1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">25877990</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heijboer</surname><given-names>AC</given-names></name><name><surname>Blankenstein</surname><given-names>MA</given-names></name><name><surname>Kema</surname><given-names>IP</given-names></name><name><surname>Buijs</surname><given-names>MM</given-names></name></person-group><article-title>Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration</article-title><source>Clin Chem</source><year>2012</year><volume>58</volume><issue>3</issue><fpage>543</fpage><lpage>548</lpage><pub-id pub-id-type="pmid">22247500</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rousseau</surname><given-names>AF</given-names></name><name><surname>Damas</surname><given-names>P</given-names></name><name><surname>Janssens</surname><given-names>M</given-names></name><name><surname>Kalin</surname><given-names>S</given-names></name><name><surname>Ledoux</surname><given-names>D</given-names></name><name><surname>Le Goff</surname><given-names>C</given-names></name><etal/></person-group><article-title>Critical care and vitamin D status assessment: what about immunoassays and calculated free 25OH-D?</article-title><source>Clin Chim Acta</source><year>2014</year><volume>437</volume><fpage>43</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">25020235</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkinson</surname><given-names>C</given-names></name><name><surname>Taylor</surname><given-names>AE</given-names></name><name><surname>Hassan-Smith</surname><given-names>ZK</given-names></name><name><surname>Adams</surname><given-names>JS</given-names></name><name><surname>Stewart</surname><given-names>PM</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name><etal/></person-group><article-title>High throughput LC-MS/MS method for the simultaneous analysis of multiple vitamin D analytes in serum</article-title><source>J Chromatogr B Anal Technol Biomed Life Sci</source><year>2016</year><volume>1014</volume><fpage>56</fpage><lpage>63</lpage></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielson</surname><given-names>CM</given-names></name><name><surname>Jones</surname><given-names>KS</given-names></name><name><surname>Chun</surname><given-names>RF</given-names></name><name><surname>Jacobs</surname><given-names>JM</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name><etal/></person-group><article-title>Free 25-Hydroxyvitamin D: impact of vitamin D binding protein assays on racial-genotypic associations</article-title><source>J Clin Endocrinol Metab</source><year>2016</year><volume>101</volume><issue>5</issue><fpage>2226</fpage><lpage>2234</lpage><pub-id pub-id-type="pmid">27007693</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chun</surname><given-names>RF</given-names></name><name><surname>Lauridsen</surname><given-names>AL</given-names></name><name><surname>Suon</surname><given-names>L</given-names></name><name><surname>Zella</surname><given-names>LA</given-names></name><name><surname>Pike</surname><given-names>JW</given-names></name><name><surname>Modlin</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D</article-title><source>J Clin Endocrinol Metab</source><year>2010</year><volume>95</volume><issue>7</issue><fpage>3368</fpage><lpage>3376</lpage><pub-id pub-id-type="pmid">20427486</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name></person-group><article-title>Vitamin D decreases adipocyte lipid storage and increases NAD-SIRT1 pathway in 3T3-L1 adipocytes</article-title><source>Nutrition</source><year>2016</year><volume>32</volume><issue>6</issue><fpage>702</fpage><lpage>708</lpage><pub-id pub-id-type="pmid">26899162</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>IM</given-names></name><name><surname>Norris</surname><given-names>KC</given-names></name><name><surname>Artaza</surname><given-names>JN</given-names></name></person-group><article-title>Vitamin D and cardiac differentiation</article-title><source>Vitam Horm</source><year>2016</year><volume>100</volume><fpage>299</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">26827957</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hlaing</surname><given-names>SM</given-names></name><name><surname>Garcia</surname><given-names>LA</given-names></name><name><surname>Contreras</surname><given-names>JR</given-names></name><name><surname>Norris</surname><given-names>KC</given-names></name><name><surname>Ferrini</surname><given-names>MG</given-names></name><name><surname>Artaza</surname><given-names>JN</given-names></name></person-group><article-title>1,25-vitamin D3 promotes cardiac differentiation through modulation of the WNT signaling pathway</article-title><source>J Mol Endocrinol</source><year>2014</year><volume>53</volume><issue>3</issue><fpage>303</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">25139490</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>S</given-names></name><name><surname>Yuan</surname><given-names>Q</given-names></name><name><surname>Mao</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>FL</given-names></name><name><surname>Ji</surname><given-names>F</given-names></name><name><surname>Cui</surname><given-names>ZH</given-names></name></person-group><article-title>Vitamin D deficiency causes insulin resistance by provoking oxidative stress in hepatocytes</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><issue>40</issue><fpage>67605</fpage><lpage>67613</lpage><pub-id pub-id-type="pmid">28978056</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beilfuss</surname><given-names>A</given-names></name><name><surname>Sowa</surname><given-names>J-P</given-names></name><name><surname>Sydor</surname><given-names>S</given-names></name><name><surname>Beste</surname><given-names>M</given-names></name><name><surname>Bechmann</surname><given-names>LP</given-names></name><name><surname>Schlattjan</surname><given-names>M</given-names></name><etal/></person-group><article-title>Vitamin D counteracts fibrogenic TGF-&#x003b2; signalling in human hepatic stellate cells both receptor-dependently and independently</article-title><source>Gut</source><year>2015</year><volume>64</volume><issue>5</issue><fpage>791</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">25134788</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Ni</surname><given-names>Y</given-names></name><name><surname>Nagata</surname><given-names>N</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Ota</surname><given-names>T</given-names></name></person-group><article-title>Micronutrient antioxidants and nonalcoholic fatty liver disease</article-title><source>Int J Mol Sci</source><year>2016</year><volume>17</volume><issue>9</issue><fpage>1379</fpage></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dirks-Naylor</surname><given-names>AJ</given-names></name><name><surname>Lennon-Edwards</surname><given-names>S</given-names></name></person-group><article-title>The effects of vitamin D on skeletal muscle function and cellular signaling</article-title><source>J Steroid Biochem Mol Biol</source><year>2011</year><volume>125</volume><issue>3</issue><fpage>159</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">21397021</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girgis</surname><given-names>CM</given-names></name><name><surname>Clifton-Bligh</surname><given-names>RJ</given-names></name><name><surname>Hamrick</surname><given-names>MW</given-names></name><name><surname>Holick</surname><given-names>MF</given-names></name><name><surname>Gunton</surname><given-names>JE</given-names></name></person-group><article-title>The roles of vitamin D in skeletal muscle: form, function, and metabolism</article-title><source>Endocr Rev</source><year>2013</year><volume>34</volume><issue>1</issue><fpage>33</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">23169676</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><mixed-citation publication-type="other">Mihajlovic M, Fedecostante M, Oost MJ, Steenhuis SKP, Lentjes E, Maitimu-Smeele I, et al. Role of vitamin D in maintaining renal epithelial barrier function in uremic conditions. Int J Mol Sci. 2017:<bold>18</bold>(12).</mixed-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shipton</surname><given-names>EA</given-names></name><name><surname>Shipton</surname><given-names>EE</given-names></name></person-group><article-title>Vitamin D and pain: vitamin D and its role in the Aetiology and maintenance of chronic pain states and associated comorbidities</article-title><source>Pain Res Treat</source><year>2015</year><volume>2015</volume><fpage>904967</fpage><pub-id pub-id-type="pmid">26090221</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalueff</surname><given-names>AV</given-names></name><name><surname>Tuohimaa</surname><given-names>P</given-names></name></person-group><article-title>Neurosteroid hormone vitamin D and its utility in clinical nutrition</article-title><source>Curr Opin Clin Nutr Metab Care</source><year>2007</year><volume>10</volume><issue>1</issue><fpage>12</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">17143049</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borgogni</surname><given-names>E</given-names></name><name><surname>Sarchielli</surname><given-names>E</given-names></name><name><surname>Sottili</surname><given-names>M</given-names></name><name><surname>Santarlasci</surname><given-names>V</given-names></name><name><surname>Cosmi</surname><given-names>L</given-names></name><name><surname>Gelmini</surname><given-names>S</given-names></name><etal/></person-group><article-title>Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells</article-title><source>Endocrinology</source><year>2008</year><volume>149</volume><issue>7</issue><fpage>3626</fpage><lpage>3634</lpage><pub-id pub-id-type="pmid">18372324</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Sims</surname><given-names>GP</given-names></name><name><surname>Chen</surname><given-names>XX</given-names></name><name><surname>Gu</surname><given-names>YY</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Lipsky</surname><given-names>PE</given-names></name></person-group><article-title>Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation</article-title><source>J Immunol</source><year>2007</year><volume>179</volume><issue>3</issue><fpage>1634</fpage><lpage>1647</lpage><pub-id pub-id-type="pmid">17641030</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sochorova</surname><given-names>K</given-names></name><name><surname>Budinsky</surname><given-names>V</given-names></name><name><surname>Rozkova</surname><given-names>D</given-names></name><name><surname>Tobiasova</surname><given-names>Z</given-names></name><name><surname>Dusilova-Sulkova</surname><given-names>S</given-names></name><name><surname>Spisek</surname><given-names>R</given-names></name><etal/></person-group><article-title>Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells</article-title><source>Clin Immunol</source><year>2009</year><volume>133</volume><issue>1</issue><fpage>69</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">19660988</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>C</given-names></name><name><surname>Wilding</surname><given-names>JP</given-names></name><name><surname>Bing</surname><given-names>C</given-names></name></person-group><article-title>1,25-dihydroxyvitamin D3 protects against macrophage-induced activation of NFkappaB and MAPK signalling and chemokine release in human adipocytes</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>4</issue><fpage>e61707</fpage><pub-id pub-id-type="pmid">23637889</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000fc;bel</surname><given-names>E</given-names></name><name><surname>Kiefer</surname><given-names>T</given-names></name><name><surname>Weber</surname><given-names>J</given-names></name><name><surname>Mettang</surname><given-names>T</given-names></name><name><surname>Kuhlmann</surname><given-names>U</given-names></name></person-group><article-title>In vivo effect of 1,25-dihydroxyvitamin D3 on phagocyte function in hemodialysis patients</article-title><source>Kidney Int</source><year>1973</year><volume>40</volume><issue>5</issue><fpage>927</fpage><lpage>933</lpage></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girasole</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>JM</given-names></name><name><surname>Pedrazzoni</surname><given-names>M</given-names></name><name><surname>Pioli</surname><given-names>G</given-names></name><name><surname>Balotta</surname><given-names>C</given-names></name><name><surname>Passeri</surname><given-names>M</given-names></name><etal/></person-group><article-title>Augmentation of monocyte chemotaxis by 1 alpha,25-dihydroxyvitamin D3. Stimulation of defective migration of AIDS patients</article-title><source>J Immunol</source><year>1990</year><volume>145</volume><issue>8</issue><fpage>2459</fpage><lpage>2464</lpage><pub-id pub-id-type="pmid">2212648</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weeres</surname><given-names>MA</given-names></name><name><surname>Robien</surname><given-names>K</given-names></name><name><surname>Ahn</surname><given-names>YO</given-names></name><name><surname>Neulen</surname><given-names>ML</given-names></name><name><surname>Bergerson</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>JS</given-names></name><etal/></person-group><article-title>The effects of 1,25 Dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) on in vitro human natural killer cell DevelopmentFrom hematopoietic stem cells</article-title><source>J Immunol</source><year>2014</year><volume>193</volume><issue>7</issue><fpage>3456</fpage><lpage>3462</lpage><pub-id pub-id-type="pmid">25149465</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amrein</surname><given-names>K</given-names></name><name><surname>Sourij</surname><given-names>H</given-names></name><name><surname>Wagner</surname><given-names>G</given-names></name><name><surname>Holl</surname><given-names>A</given-names></name><name><surname>Pieber</surname><given-names>TR</given-names></name><name><surname>Smolle</surname><given-names>KH</given-names></name><etal/></person-group><article-title>Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study</article-title><source>Critical care</source><year>2011</year><volume>15</volume><issue>2</issue><fpage>R104</fpage><pub-id pub-id-type="pmid">21443793</pub-id></element-citation></ref><ref id="CR124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leaf</surname><given-names>DE</given-names></name><name><surname>Raed</surname><given-names>A</given-names></name><name><surname>Donnino</surname><given-names>MW</given-names></name><name><surname>Ginde</surname><given-names>AA</given-names></name><name><surname>Waikar</surname><given-names>SS</given-names></name></person-group><article-title>Randomized controlled trial of calcitriol in severe sepsis</article-title><source>Am J Respir Crit Care Med</source><year>2014</year><volume>190</volume><issue>5</issue><fpage>533</fpage><lpage>541</lpage><pub-id pub-id-type="pmid">25029202</pub-id></element-citation></ref><ref id="CR125"><label>125.</label><mixed-citation publication-type="other">Quraishi SA, De Pascale G, Needleman JS, Nakazawa H, Kaneki M, Bajwa EK <italic>et al</italic>: Effect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in Sepsis: a randomized, Placebo-Controlled Trial <italic>Crit Care Med</italic> 2015, 43(9):1928&#x02013;1937.</mixed-citation></ref><ref id="CR126"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>P</given-names></name><name><surname>Venkatesh</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>P</given-names></name><name><surname>Kerr</surname><given-names>S</given-names></name><name><surname>Hoechter</surname><given-names>DJ</given-names></name><name><surname>Dimeski</surname><given-names>G</given-names></name><etal/></person-group><article-title>A randomized study of a single dose of intramuscular cholecalciferol in critically ill adults</article-title><source>Crit Care Med</source><year>2015</year><volume>43</volume><issue>11</issue><fpage>2313</fpage><lpage>2320</lpage><pub-id pub-id-type="pmid">26186566</pub-id></element-citation></ref><ref id="CR127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>JE</given-names></name><name><surname>Jones</surname><given-names>JL</given-names></name><name><surname>Tangpricha</surname><given-names>V</given-names></name><name><surname>Brown</surname><given-names>MA</given-names></name><name><surname>Brown</surname><given-names>LA</given-names></name><name><surname>Hao</surname><given-names>L</given-names></name><etal/></person-group><article-title>High dose vitamin D Administration in Ventilated Intensive Care Unit Patients: a pilot double blind randomized controlled trial</article-title><source>J Clin Trans Endocrin</source><year>2016</year><volume>4</volume><fpage>59</fpage><lpage>65</lpage></element-citation></ref><ref id="CR128"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alizadeh</surname><given-names>N</given-names></name><name><surname>Khalili</surname><given-names>H</given-names></name><name><surname>Mohammadi</surname><given-names>M</given-names></name><name><surname>Abdollahi</surname><given-names>A</given-names></name><name><surname>Ala</surname><given-names>S</given-names></name></person-group><article-title>Effect of vitamin D on stress-induced hyperglycaemia and insulin resistance in critically ill patients</article-title><source>Int J Clin Pract</source><year>2016</year><volume>70</volume><issue>5</issue><fpage>396</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">27091752</pub-id></element-citation></ref><ref id="CR129"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>JE</given-names></name><name><surname>Alvarez</surname><given-names>JA</given-names></name><name><surname>Jones</surname><given-names>JL</given-names></name><name><surname>Tangpricha</surname><given-names>V</given-names></name><name><surname>Brown</surname><given-names>MA</given-names></name><name><surname>Hao</surname><given-names>L</given-names></name><etal/></person-group><article-title>Impact of high-dose vitamin D3 on plasma free 25-hydroxyvitamin D concentrations and antimicrobial peptides in critically ill mechanically ventilated adults</article-title><source>Nutrition</source><year>2017</year><volume>38</volume><fpage>102</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">28526374</pub-id></element-citation></ref></ref-list></back></article>